{"custom_id": "drug2_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"RAD-140\" (also known as \"rad-140\"), here are the article titles and their IDs:\n893: RAD-140 Drug-Induced Liver Injury\n894: Drug-Induced Liver Injury Associated With Alpha Bolic (RAD-140) and Alpha Elite (RAD-140 and LGD-4033)\n895: Comparison of the three SARMs RAD-140, GLPG0492 and GSK-2881078 in two different in vitro bioassays, and in an in silico androgen receptor binding assay\n897: Acute Myocarditis From the Use of Selective Androgen Receptor Modulator (SARM) RAD-140 (Testolone)\n900: Severe liver injury following use of RAD-140, a selective androgen receptor modulator, for body building\n903: Myopericarditis Following Use of Selective Androgen Receptor Modifier \"RAD-140\"\n905: Selective androgen receptor modulator abuse-induced heart failure: catastrophic effects of RAD-140 (Testolone)\n908: RAD140 (Testolone) negatively impacts skeletal muscle adaptation, frailty status and mortality risk in female mice\n914: Label-free proteomics for discovering biomarker candidates of RAD140 administration to castrated horses\n917: A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer\n920: Human In Vivo Metabolism and Elimination Behavior of Micro-Dosed Selective Androgen Receptor Modulator RAD140 for Doping Control Purposes\n923: Comparison of in vitro approaches for predicting the metabolism of the selective androgen receptor modulator RAD140\n925: Idiosyncratic drug-induced liver injury related to use of novel selective androgen receptor modulator RAD140 (Testalone): a case report\n929: Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140\n932: Selective androgen receptor modulator RAD140 is neuroprotective in cultured neurons and kainate-lesioned male rats\n935: Expanding sports drug testing assays: mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105\n939: Selective Androgen Receptor Modulator RAD140 Inhibits the Growth of Androgen/Estrogen Receptor-Positive Breast Cancer Models with a Distinct Mechanism of Action\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug3_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"GW-501516\" (also known as \"gw-501516\"), here are the article titles and their IDs:\n902: PPARdelta activator GW-501516 has no acute effect on glucose transport in skeletal muscle\n904: Synthesis, biological evaluation and molecular modeling of GW 501516 analogues\n906: Synthesis, molecular modeling studies and biological evaluation of fluorine substituted analogs of GW 501516\n910: Synthesis and dual PPARalpha/delta agonist effects of 1,4-disubstituted 1,2,3-triazole analogues of GW 501516\n913: Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination\n919: PPAR\u03b4 Agonist GW501516 Suppresses the TGF-\u03b2-Induced Profibrotic Response of Human Bronchial Fibroblasts from Asthmatic Patients\n922: GW501516-Mediated Targeting of Tetraspanin 15 Regulates ADAM10-Dependent N-Cadherin Cleavage in Invasive Bladder Cancer Cells\n926: Metabolic modulators of the exercise response: doping control analysis of an agonist of the peroxisome proliferator-activated receptor \u03b4 (GW501516) and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR)\n931: Selective PPAR\u03b4 Agonist GW501516 Protects Against LPS-Induced Macrophage Inflammation and Acute Liver Failure in Mice via Suppressing Inflammatory Mediators\n937: Early controlled release of peroxisome proliferator-activated receptor \u03b2/\u03b4 agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment\n940: PPAR\u03b2/\u03b4 agonist GW501516 inhibits TNF\u03b1-induced repression of adiponectin and insulin receptor in 3T3-L1 adipocytes\n942: Comprehensive characterization of the peroxisome proliferator activated receptor-\u03b4 agonist GW501516 for horse doping control analysis\n943: [Effects of GW501516 on the proliferation of pulmonary artery smooth muscle cells induced by hypoxia and its mechanisms]\n944: Highly selective peroxisome proliferator-activated receptor \u03b4 (PPAR\u03b4) modulator demonstrates improved safety profile compared to GW501516\n946: A metabolomic study of the PPAR\u03b4 agonist GW501516 for enhancing running endurance in Kunming mice\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug5_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"BPC-157\" (also known as \"bpc-157\"), here are the article titles and their IDs:\n949: Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing\n952: BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing\n955: The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration\n959: Pentadecapeptide BPC 157 and the central nervous system\n962: Stable Gastric Pentadecapeptide BPC 157 and Wound Healing\n965: Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle\n967: Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis Function\n970: BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection\n972: Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain\n973: Stable Gastric Pentadecapeptide BPC 157-Possible Novel Therapy of Glaucoma and Other Ocular Conditions\n975: Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy\n977: BPC 157 and blood vessels\n979: Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation\n981: The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity\n983: Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future\n986: Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications\n988: BPC 157 as Potential Treatment for COVID-19\n990: Stable gastric pentadecapeptide BPC 157-NO-system relation\n991: Stable Gastric Pentadecapeptide BPC 157 and Intestinal Anastomoses Therapy in Rats-A Review\n994: Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing\n995: Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome\n998: Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract\n1001: BPC 157, L-NAME, L-Arginine, NO-Relation, in the Suited Rat Ketamine Models Resembling \"Negative-Like\" Symptoms of Schizophrenia\n1002: Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study\n1004: The anti-nociceptive effect of BPC-157 on the incisional pain model in rats\n1006: Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?\n1008: Pentadecapeptide BPC 157 as Therapy for Inferior Caval Vein Embolization: Recovery of Sodium Laurate-Post-Embolization Syndrome in Rats\n1010: Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma\n1012: Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157\n1014: BPC 157 Therapy and the Permanent Occlusion of the Superior Sagittal Sinus in Rat: Vascular Recruitment\n1016: Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid accumulation through Kruppel-like factor 4 upregulation both in vivo and in vitro\n1018: Stable Gastric Pentadecapeptide BPC 157 May Counteract Myocardial Infarction Induced by Isoprenaline in Rats\n1020: Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophrenia\n1022: BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats\n1024: Pentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion\n1026: BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmias\n1028: Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats\n1030: Stable Gastric Pentadecapeptide BPC 157 Therapy: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension (Grade III and IV) in Rats\n1032: Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157\n1035: Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect\n1039: Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats\n1043: Pentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein, Budd-Chiari syndrome model in rats\n1045: Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response\n1048: The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats\n1051: BPC 157's effect on healing\n1055: Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation\n1059: Stable Gastric Pentadecapeptide BPC 157 Heals Established Vesicovaginal Fistula and Counteracts Stone Formation in Rats\n1062: Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway\n1064: Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in rats\n1067: Stable gastric pentadecapeptide BPC 157 and bupivacaine\n1071: Corrigendum: Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats\n1074: Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention and Reversal\n1077: BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats\n1080: Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats\n1084: Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts\n1088: Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator\n1090: Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula\n1092: Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy\n1097: Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 Therapy\n1100: Stable Isotope Labeling-Based Nontargeted Strategy for Characterization of the In Vitro Metabolic Profile of a Novel Doping BPC-157 in Doping Control by UHPLC-HRMS\n1102: Stable gastric pentadecapeptide BPC 157 heals rectovaginal fistula in rats\n1105: BPC 157 antagonized the general anaesthetic potency of thiopental and reduced prolongation of anaesthesia induced by L-NAME/thiopental combination\n1109: Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine\n1111: Perforating corneal injury in rat and pentadecapeptide BPC 157\n1114: Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin\n1118: Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress\n1123: Fourier Transform Infrared Spectroscopy Reveals Molecular Changes in Blood Vessels of Rats Treated with Pentadecapeptide BPC 157\n1125: Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights\n1128: Over-Dose Lithium Toxicity as an Occlusive-like Syndrome in Rats and Gastric Pentadecapeptide BPC 157\n1131: Occluded Superior Mesenteric Artery and Vein. Therapy with the Stable Gastric Pentadecapeptide BPC 157\n1134: Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy\n1135: Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as Therapy\n1138: Complex Syndrome of the Complete Occlusion of the End of the Superior Mesenteric Vein, Opposed with the Stable Gastric Pentadecapeptide BPC 157 in Rats\n1141: Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances\n1147: Bowel adhesion and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in rats\n1151: Duodenocolic fistula healing by pentadecapeptide BPC 157 in rats. A cytoprotection viewpoint\n1154: In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro\n1157: BPC 157 therapy to detriment sphincters failure-esophagitis-pancreatitis in rat and acute pancreatitis patients low sphincters pressure\n1161: Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats\n1162: Clopidogrel-Induced Gastric Injury in Rats is Attenuated by Stable Gastric Pentadecapeptide BPC 157\n1166: Therapy Effect of the Stable Gastric Pentadecapeptide BPC 157 on Acute Pancreatitis as Vascular Failure-Induced Severe Peripheral and Central Syndrome in Rats\n1169: Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates, L-NAME and L-arginine worsen\n1172: Esophagogastric anastomosis in rats: Improved healing by BPC 157 and L-arginine, aggravated by L-NAME\n1175: Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat\n1177: Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H\n1180: Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice\n1182: Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities\n1184: Pentadecapeptide BPC 157 and anaphylactoid reaction in rats and mice after intravenous dextran and white egg administration\n1185: Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension\n1187: Robert's Intragastric Alcohol-Induced Gastric Lesion Model as an Escalated General Peripheral and Central Syndrome, Counteracted by the Stable Gastric Pentadecapeptide BPC 157\n1188: Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat\n1191: Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth\n1193: Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system\n1195: Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats\n1197: Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats\n1199: The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks\n1201: Physiological and Immunological Status of Adult Honeybees (Apis mellifera) Fed Sugar Syrup Supplemented with Pentadecapeptide BPC 157\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug4_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"HCG\" (also known as \"hcg\"), here are the article titles and their IDs:\n950: Hyperglycosylated hCG: a Unique Human Implantation and Invasion Factor\n951: [Influence of hCG glycosylation on its functions in female reproduction]\n966: Hyperglycosylated hCG activates LH/hCG-receptor with lower activity than hCG\n969: Recurrent miscarriage and hCG supplementation: a review and metaanalysis\n971: Clinical use of HCG and hCG beta determinations\n974: Hyperglycosylated hCG: a variant with separate biological functions to regular hCG\n982: On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation\n985: Persistently elevated serum concentrations of human chorionic gonadotropin (hCG)\n987: Hyperglycosylated hCG and pregnancy failures\n1003: Effect of GnRH and hCG injection on the reproductive performance and serum progesterone concentration of ewes during spring season\n1007: Use of the rat model to study hCG/LH effects on uterine blood flow\n1013: hCG production by mucinous adenocarcinoma of the ovary in a reproductive aged woman\n1015: Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases\n1021: hCG treatment on day of mating improves embryo viability and fertility in ewe lambs\n1023: Does hCG or hCG\u03b2 play a role in cancer cell biology?\n1025: Effects of hCG on reduced numbers of hCG receptors in the prefrontal cortex and cerebellum of rat models of Alzheimer's disease\n1027: Combined analysis of clinical features, human chorionic gonadotropin (hCG) value, and hCG ratios for early prediction of postmolar gestational trophoblastic neoplasia\n1029: The application of single beta-human chorionic gonadotropin (\u03b2-hCG) level measurement in women undergoing single blastocyst transfer\n1041: Effect of additional human chorionic gonadotrophin (hCG) on follicular growth and ovulation in gonadotrophin-treated gilts\n1047: beta-HCG/LH receptor (beta-HCG/LH-R) expression in eutopic endometrium and endometriotic implants: evidence for beta-HCG sensitivity of endometriosis\n1050: Clinical Pregnancy and Incidence of Ovarian Hyperstimulation Syndrome in High Ovarian Responders Receiving Different Doses of hCG Supplementation in a GnRH-Agonist Trigger Protocol\n1058: Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy\n1065: [Mechanism of regulation of synthesis and secretion of human chorionic gonadotropin (hCG) during pregnancy]\n1068: BRCA1 regulation on \u03b2-hCG: a mechanism for tumorigenicity in BRCA1 defective breast cancer\n1079: [Studies on the thyrotropic activity of hCG and its derivatives]\n1082: Human chorionic gonadotropin (hCG) in the secretome of cultured embryos: hyperglycosylated hCG and hCG-free beta subunit are potential markers for infertility management and treatment\n1085: Review: hCGs: different sources of production, different glycoforms and functions\n1087: [The human chorionic gonadotropin (hCG) receptor: a new class within the family of GTP protein coupled receptors. Epitope mapping of receptor-bound agonistic and antagonistic forms of hCG]\n1099: Human chorionic gonadotropin (hCG) plasma levels at oocyte retrieval and IVF outcomes\n1103: The interplay of human chorionic gonadotropin (hCG) with basic fibroblast growth factor and adipokines on angiogenesis in vitro\n1106: Dual trigger of triptorelin and HCG optimizes clinical outcome for high ovarian responder in GnRH-antagonist protocols\n1115: Choriocarcinoma-like human chorionic gonadotrophin (HCG) and HCG bioactivity during the first trimester of pregnancy\n1117: Quantitative urine hCG and urine pregnancy test in gestational trophoblastic disease patients with low hCG titer\n1120: [HCG in serum and peritoneal fluid in suspected ectopic pregnancy]\n1129: Hyperthyroidism induced by paraneoplastic human chorionic gonadotropin (hCG) production from testicular tumours: a retrospective clinical and histopathological study\n1132: Physiological studies of human chorionic gonadotropin (hCG), alpha hCG, and beta hCG as measured by specific monoclonal immunoradiometric assays\n1136: The effect of hCG treatment on Day 12 post-mating on ovarian function and reproductive performance of ewes and ewe lambs\n1143: Comparative Effects of Different Dosages of hCG on Follicular Development in Postpartum Dairy Cows With Cystic Ovarian Follicles\n1149: Role of HCG and inhibin in breast-cancer (review)\n1164: Urine reference intervals for human chorionic gonadotropin (hCG) isoforms by immunoextraction-tandem mass spectrometry to detect hCG use\n1167: Rat as model for studying behavior effects of hCG\n1171: A Subovulatory Dose of Human Chorionic Gonadotropin (hCG) May Sustain Terminal Follicle Development and Reproductive Efficiency during Anestrus in Sheep\n1178: Temporal relationship between hCG induced desensitization of LH/hCG responsive adenylyl cyclase and downregulation of LH/hCG receptors in the rat testis\n1181: Effect of an antiestrogen on the testicular response to acute and chronic administration of hCG in normal and hypogonadotropic hypogonadic men: tamoxifen and testicular response to hCG\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug7_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Clomiphene\" (also known as \"clomiphene\"), here are the article titles and their IDs:\n1034: Clomiphene Citrate for the Treatment of Hypogonadism\n1046: Clomiphene citrate in the twenty-first century\n1049: Clomiphene citrate therapy for male infertility\n1057: Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity againstMycobacterium abscessus\n1060: Development, pharmacology and clinical experience with clomiphene citrate\n1075: Comparative effectiveness of 9 ovulation-induction therapies in patients with clomiphene citrate-resistant polycystic ovary syndrome: a network meta-analysis\n1078: Depletion of clomiphene residues in eggs and muscle after oral administration to laying hens\n1086: Clomiphene citrate and ovulation induction\n1089: [Pro clomiphene]\n1093: A rare case of clomiphene-induced leukocytoclastic vasculitis\n1107: Is ultrasound monitoring of the ovaries during ovulation induction by clomiphene citrate essential? A systematic review\n1110: Corifollitropin alpha, clomiphene citrate and dydrogesterone without daily gonadotrophin: a new option of a friendly protocol for high-responder oocyte donors\n1121: Assessing human urinary clomiphene metabolites after consumption of eggs from clomiphene-treated laying hens using chromatographic-mass spectrometric approaches\n1124: Low-dosage clomiphene reduces premature ovulation rates and increases transfer rates in natural-cycle IVF\n1127: Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency\n1142: [Clomiphene-exposed pregnancies--analysis of 39 information requests including 25 cases with known outcome]\n1145: Quantification of clomiphene metabolite isomers in human plasma by rapid-resolution liquid chromatography-electrospray ionization-tandem mass spectrometry\n1148: Clomiphene citrate treatment in oligozoospermia: comparison between two regimens of low-dose treatment\n1155: Use of clomiphene citrate in infertile women: a committee opinion\n1163: [Clomiphene resistant PCO syndrome: IVF treatment as an alternative in failed gonadotropin treatment]\n1168: Visual disturbance secondary to clomiphene citrate\n1173: Acupuncture and clomiphene for Chinese women with polycystic ovary syndrome (PCOSAct): statistical analysis approach with the revision and explanation\n1186: Update on the safety and efficacy of clomiphene citrate as a therapeutic agent\n1189: Clomiphene citrate 'stair-step' protocol vs. traditional protocol in patients with polycystic ovary syndrome: a randomized controlled trial\n1190: Clomiphene citrate does not modify the exaggerated thyrotrophin response to thyrotrophin-releasing hormone occurring in primary testicular failure\n1192: Single-dose pharmacokinetics of clomiphene citrate in normal volunteers\n1202: Clinical trial of clomiphene in advanced breast cancer\n1203: Mass spectrometric identification and characterization of new clomiphene metabolites in human urine by liquid chromatography-quadrupole time-of-flight tandem mass spectrometry\n1205: Ovulation induction with low doses of clomiphene citrate\n1206: Ovulation induction with clomiphene and the rise in heterotopic pregnancies. A report of two cases\n1207: Outcome of pregnancy after clomiphene therapy\n1208: Pregnancy outcome following frozen embryo transfer after artificial cycle or treatment by clomiphene citrate\n1209: Monitoring plasma concentrations to individualize treatment with clomiphene citrate\n1214: Interest of hair tests and supplement tests to discriminate a tail end of a doping regimen from a supplement contamination in case of challenging an anti-doping rule violation. VII. Case example with clomiphene\n1215: Ovulation and pregnancy rates with clomiphene citrate\n1216: A comparison of the effects on follicular development between clomiphene citrate, its two separate isomers and spontaneous cycles\n1217: An association between clomiphene citrate and ectopic pregnancy: a preliminary report\n1219: Testicular germ cell tumors after clomiphene therapy for subfertility\n1223: Genetic polymorphism of cytochrome P450 2D6 determines oestrogen receptor activity of the major infertility drug clomiphene via its active metabolites\n1225: Blockade of ovulation by clomiphene citrate and its reversal by human chorionic gonadotropin or prostaglandin F2 alpha in rats\n1230: Progestin-primed ovarian stimulation with or without clomiphene citrate supplementation in normal ovulatory women undergoing in vitro fertilization/intracytoplasmic sperm injection: A prospective randomized controlled trial\n1238: Determination by liquid chromatography-mass spectrometry of clomiphene isomers in the plasma of patients undergoing treatment for the induction of ovulation\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug8_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Tamoxifen\" (also known as \"tamoxifen\"), here are the article titles and their IDs:\n1226: Tamoxifen in men: a review of adverse events\n1229: Tamoxifen and CYP2D6: A Controversy in Pharmacogenetics\n1231: Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications\n1235: Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis\n1240: Tamoxifen-induced acute mania: A case report\n1241: Tamoxifen to raloxifene and beyond\n1243: Tamoxifen in the treatment of breast cancer\n1244: Tamoxifen: catalyst for the change to targeted therapy\n1247: Tamoxifen resistance in breast cancer\n1249: Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use\n1251: Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer\n1252: Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives\n1253: [Research Progress in the Role of Tamoxifen in Nervous System and Cognitive Function]\n1255: Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects\n1258: Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer\n1262: Tamoxifen as adjuvant therapy in breast cancer. Current status\n1264: Tamoxifen's impact on the management of breast cancer: the oncologist's perspective\n1268: Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance\n1269: Tamoxifen, screening and new oestrogen receptor modulators\n1271: Tamoxifen metabolism and its effect on endocrine treatment of breast cancer\n1274: Tamoxifen's role in chemoprevention of breast cancer: an update\n1276: Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy\n1277: Acquired tamoxifen resistance in human breast cancer--potential mechanisms and clinical implications\n1281: Tamoxifen maculopathy: The importance of screening and long follow-up\n1283: [Tamoxifen in the treatment of breast cancer]\n1291: 50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened?\n1293: Clinical efficacy of tamoxifen\n1294: [Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects]\n1296: Serine synthesis influences tamoxifen response in ER+ human breast carcinoma\n1298: [Tamoxifen treatment and pulmunary embolism: a case report and literature review]\n1307: Controversies regarding tamoxifen and uterine carcinoma\n1309: Tamoxifen metabolites treatment promotes ER\u03b1+ transition to triple negative phenotype in vitro, effects of LDL in chemoresistance\n1313: Tamoxifen inhibits mitochondrial membrane damage caused by disulfiram\n1314: Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer\n1315: Delineating the molecular mechanisms of tamoxifen's oncolytic actions in estrogen receptor-negative cancers\n1316: Mechanisms for tamoxifen resistance in breast cancer: possible role of tamoxifen metabolism\n1317: Prolonged tamoxifen-enriched diet is associated with cardiomyopathy and nutritional frailty in mice\n1318: [Isolated superior ophthalmic vein thrombosis due to tamoxifen]\n1320: Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug\n1322: Interaction of tamoxifen's impact on overall net mortality and quality of life\n1323: Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients\n1324: The inhibition of tamoxifen on UGT2B gene expression and enzyme activity in rat liver contribute to the estrogen homeostasis dysregulation\n1325: A realistic clinical perspective of tamoxifen and endometrial carcinogenesis\n1326: Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial\n1327: Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer\n1329: Vaginal tamoxifen for treatment of vulvar and vaginal atrophy: Pharmacokinetics and local tolerance in a rabbit model over 28 days\n1330: Investigating the molecular mechanisms of Tamoxifen on the EMT pathway among patients with breast cancer\n1332: A risk-benefit assessment of tamoxifen therapy\n1333: Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors\n1336: Variation in human gut microbiota impacts tamoxifen pharmacokinetics\n1339: Effects of tamoxifen and glutamate and glutamine levels in brain regions in repeated sleep deprivation-induced mania model in mice\n1340: Single-Cell Screening of Tamoxifen Abundance and Effect Using Mass Spectrometry and Raman-Spectroscopy\n1341: Individualized Tamoxifen Dose Escalation: Confirmation of Feasibility, Question of Utility\n1342: Developmental malformations resulting from high-dose maternal tamoxifen exposure in the mouse\n1344: CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine\n1346: Interaction of neutral and protonated Tamoxifen with the DPPC lipid bilayer using molecular dynamics simulation\n1348: Comprehensive understanding of multiple actions of anticancer drug tamoxifen in isolated mitochondria\n1350: An electrochemical outlook on tamoxifen biotransformation: current and future prospects\n1354: Potential role of tamoxifen in prevention of breast cancer\n1355: Tamoxifen modulates cell migration and expression of angiogenesis-related genes in human endometrial endothelial cells\n1357: Persistent Metabolic Effects of Tamoxifen: Considerations for an Experimental Tool and Clinical Breast Cancer Treatment\n1359: [Uterine sarcoma associated with tamoxifen use after breast cancer: Review of the pathogenesis]\n1361: [Antidepressants and tamoxifen: an unrecognized interaction]\n1363: Low concentrations of 17\u03b2-estradiol exacerbate tamoxifen resistance in breast cancer treatment through membrane estrogen receptor-mediated signaling pathways\n1365: Bone health in postmenopausal women with early breast cancer: how protective is tamoxifen?\n1366: How long should adjuvant tamoxifen be continued?\n1368: Reduction in Tamoxifen Metabolites Endoxifen and N-desmethyltamoxifen With Chronic Administration of Low Dose Cannabidiol: A CYP3A4 and CYP2D6 Drug Interaction\n1372: Interaction of tamoxifen and noise-induced damage to the cochlea\n1374: Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer\n1377: The Breast Cancer Prevention Trial: evaluating tamoxifen's efficacy in preventing breast cancer\n1383: Tamoxifen's clinical applications: old and new\n1385: Tamoxifen-like metallocifens target the thioredoxin system determining mitochondrial impairment leading to apoptosis in Jurkat cells\n1387: Tamoxifen in the treatment and chemoprevention of breast cancer\n1389: Tamoxifen chemoprevention treatment and time to first diagnosis of estrogen receptor-negative breast cancer\n1391: [Endometrial cancers arising in polyps associated with tamoxifen use]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug12_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Andarine\" (also known as \"andarine\"), here are the article titles and their IDs:\n1331: In vitro anti-carcinogenic effect of andarine as a selective androgen receptor modulator on MIA-PaCa-2 cells by decreased proliferation and cell-cycle arrest at G0/G1 phase\n1334: Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes\n1337: Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug14_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Melanotanii\" (also known as \"melanotanii\"), here are the article titles and their IDs:\n1343: CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists\n1345: Melanoma associated with the use of melanotan-II\n1347: Melanotan-II reverses memory impairment induced by a short-term HF diet\n1351: Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food\n1353: Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism\n1356: The unregulated use of melanotan-II is of public health interest to Australian dermatologists\n1358: Effect of Melanotan-II on Brain Fos Immunoreactivity and Oxytocin Neuronal Activity and Secretion in Rats\n1360: Preformulation studies with melanotan-II: a potential skin cancer chemopreventive peptide\n1362: Co-treatment with melanotan-II, a potent melanocortin, does not protect against cisplatin ototoxicity\n1364: The melanocortin agonist, melanotan II, enhances proceptive sexual behaviors in the female rat\n1367: High-performance liquid chromatographic assay for the alpha-melanotropin[4,10] fragment analogue (Melanotan-II) in rat plasma\n1369: Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study\n1371: A comparison of HPLC and bioassay methods for plasma melanotan-II (MT-II) determination: application to a pharmacokinetic study in rats\n1373: The use of telemetry technology to test the proerectile effect of melanotan-II (MT-II) in conscious rats\n1376: Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice\n1378: The potent melanocortin receptor agonist melanotan-II promotes peripheral nerve regeneration and has neuroprotective properties in the rat\n1380: Reduced anorexigenic efficacy of leptin, but not of the melanocortin receptor agonist melanotan-II, predicts diet-induced obesity in rats\n1381: Melanotan-II: Investigation of the inducer and facilitator effects on penile erection in anaesthetized rat\n1384: 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats\n1386: Inhibitory Effect of the Melanocortin Receptor Agonist Melanotan-II (MTII) on Feeding Depends on Dietary Fat Content and not Obesity in Rats on Free-Choice Diets\n1388: The protective effects of the melanocortin receptor (MCR) agonist, melanotan-II (MTII), against binge-like ethanol drinking are facilitated by deletion of the MC3 receptor in mice\n1390: A liquid chromatographic/tandem mass spectroscopic method for quantification of the cyclic peptide melanotan-II. Plasma and brain tissue concentrations following administration in mice\n1392: The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat\n1393: Effects of ghrelin, corticotrophin-releasing hormone, and melanotan-II on food intake in rats with paraventricular nucleus lesions\n1394: Determination of melanotan-II in rat plasma by liquid chromatography/tandem mass spectrometry: determination of pharmacokinetic parameters in rat following intravenous administration\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug15_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Anastrozole\" (also known as \"anastrozole\"), here are the article titles and their IDs:\n1395: Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial\n1396: Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial\n1397: Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial\n1400: Anastrozole Regulates Fatty Acid Synthase in Breast Cancer\n1401: Anastrozole plus fulvestrant vs. anastrozole alone for hormone receptor-positive advanced breast cancer: a meta-analysis of randomized controlled trials\n1402: The Effect of Anastrozole on the Lipid Profile: Systematic Review and Meta-analysis of Randomized Controlled Trials\n1403: Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial\n1404: Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial\n1405: Efficacy and safety of letrozole or anastrozole in the treatment of male infertility with low testosterone-estradiol ratio: A meta-analysis and systematic review\n1407: Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled Trial\n1408: Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study\n1409: Anastrozole (Arimidex)--an aromatase inhibitor for the adjuvant setting?\n1411: Anastrozole: a new addition to the armamentarium against advanced breast cancer\n1412: Anastrozole in the management of breast cancer\n1413: Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial\n1414: Anastrozole: a selective aromatase inhibitor for the treatment of breast cancer\n1415: In case of anastrozole-related hallucinations, can switching to letrozole be a treatment option? A case report and literature review\n1416: Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8\n1417: Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial\n1418: Anastrozole-mediated modulation of mitochondrial activity by inhibition of mitochondrial permeability transition pore opening: an initial perspective\n1420: Anastrozole--a new generation in aromatase inhibition: clinical pharmacology\n1421: Combination Vistusertib and Anastrozole Shows Benefit in Endometrial Cancer\n1423: Anastrozole may aid breast cancer prevention\n1425: The effect of anastrozole therapy on final height and sex hormone levels in pubertal boys receiving growth hormone therapy\n1427: Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor \u03b1\n1428: A novel anastrozole intravaginal ring for endometriosis: Pharmacokinetic characteristics and mucosal irritation\n1429: Combined Anastrozole and Antiplatelet Therapy Treatment Differentially Promotes Breast Cancer Cell Survival\n1431: Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients\n1432: Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2\n1433: Overexpression of BQ323636.1 contributes to anastrozole resistance in AR+ve/ER+ve breast cancer\n1434: Anastrozole as a therapeutic option for gynecomastia in a person receiving antiretroviral therapy: Case report\n1435: Effects of psoralen on the pharmacokinetics of anastrozole in rats\n1436: Anastrozole-induced pulmonary cryptococcosis in a patient with early breast cancer: A case report\n1437: Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer\n1438: Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer\n1440: Testosterone and luteinizing hormone predict semen parameter improvement in infertile men treated with anastrozole\n1441: Anastrozole is a dose-specific superovulator and favors implantation in rats: a prospective study\n1442: Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy\n1443: Aromatase inhibitor anastrozole modifies cellular functions in gingival fibroblasts and endothelial cells: possible periodontal complications of aromatase inhibitor treatment\n1444: Anastrozole-induced liver injury after a prolonged latency: a very rare complication of a commonly prescribed medication\n1445: Pharmacokinetic evaluation of a transdermal anastrozole-in-adhesive formulation\n1447: Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability\n1448: Modelling the procoagulatory effect of Anastrozole relative to ER\u03b1 and ER\u03b2 expression in breast cancer cells\n1450: Effects ofCYP3A4andCYP2C9genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226\n1452: Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer\n1454: Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole\n1456: First-line fulvestrant plus anastrozole for hormone-receptor-positive metastatic breast cancer in postmenopausal women: a cost-effectiveness analysis\n1458: Breast Tumor Cells Evade the Cytotoxic Action of Anastrozole, Aspirin, and Clopidogrel Cocktail\n1462: Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer\n1463: Evaluation of Pharmacokinetics and Safety With Bioequivalence of Anastrozole in Healthy Chinese Volunteers: Bioequivalence Study Findings\n1465: Anastrozole. An effective, second-line hormonal treatment for advanced breast cancer\n1467: Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure\n1469: Trajectories of neuropsychological symptom burden in postmenopausal women prescribed anastrozole for early-stage breast cancer\n1471: Amalgamation of quercetin with anastrozole and capecitabine: A novel combination to treat breast and colon cancers - Anin vitrostudy\n1475: Parahydrogen in Reversible Exchange Induces Long-Lived15N Hyperpolarization of Anticancer Drugs Anastrozole and Letrozole\n1478: Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast Cancer\n1483: Phase 2 study of anastrozole in rare cohorts of patients with estrogen receptor/progesterone receptor positive leiomyosarcomas and carcinosarcomas of the uterine corpus: The PARAGON trial (ANZGOG 0903)\n1486: Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903)\n1488: Aromatase inhibitor (anastrozole) affects growth of endometrioma cells in culture\n1490: Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Male Volunteers: A Randomized, Single-Dose, Two-Period, Two-Sequence Crossover Study\n1495: The effects of anastrozole on the proliferation of FM3A cells\n1499: Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action\n1501: Effects of anastrozole on Ki-67 antigen expression in the vaginal epithelium of female rats in persistent estrus\n1504: Antiplatelet Therapy Combined with Anastrozole Induces Features of Partial EMT in Breast Cancer Cells and Fails to Mitigate Breast-Cancer Induced Hypercoagulation\n1507: Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results\n1513: Segmental Erythema Multiforme: An Unusual Drug Reaction to Anastrozole\n1516: Anastrozole as neoadjuvant therapy for patients with hormone-dependent, locally-advanced breast cancer\n1519: Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group\n1522: Exploring Radioiodinated Anastrozole and Epirubicin as AKT1-Targeted Radiopharmaceuticals in Breast Cancer: In Silico Analysis and Potential Therapeutic Effect with Functional Nuclear Imagining Implications\n1528: Palliative treatment of endometrial cancer: what is the role of anastrozole in elderly women?\n1535: Optic Neuritis as a Consequence of Long-Term Medical Treatment Using Anastrozole: A Case Report\n1539: Breast cancer cell-induced platelet activation is compounded by tamoxifen and anastrozole in vitro\n1542: Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor-Positive Recurrent or Metastatic Endometrial Cancer: The VICTORIA Multicenter, Open-label, Phase 1/2 Randomized Clinical Trial\n1547: Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903\n1550: Half-dose fulvestrant plus anastrozole as a first-line treatment for hormone receptor-positive metastatic breast cancer: a cost-effectiveness analysis\n1554: Anastrozole monotherapy further improves near-adult height after the initial combined treatment with leuprorelin and anastrozole in early-maturing girls with compromised growth prediction: results from the second phase of the GAIL study\n1560: Simultaneous Method Development and Validation of Anastrozole Along with Piperine: Degradation Studies and Degradants Characterization Using LC-QTOF-ESI-MS Along with In-silico ADMET Predictions\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug18_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Glutathione\" (also known as \"glutathione\"), here are the article titles and their IDs:\n1453: Unraveling the Potential Role of Glutathione in Multiple Forms of Cell Death in Cancer Therapy\n1455: An Update on Glutathione's Biosynthesis, Metabolism, Functions, and Medicinal Purposes\n1461: Glutathione and glutathione delivery compounds\n1464: Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy\n1473: Glutathione and glutathione analogues; therapeutic potentials\n1476: Glutathione metabolism and its role in hepatotoxicity\n1480: Role of glutathione metabolism and glutathione-related antioxidant defense systems in hypertension\n1508: Glutathione Pulse Therapy: Promote Spatiotemporal Delivery of Reduction-Sensitive Nanoparticles at the \"Cellular Level\" and Synergize PD-1 Blockade Therapy\n1512: Elevation of mouse kidney thiol content following administration of glutathione\n1548: Glutathione monoethyl ester prevents TDP-43 pathology in motor neuronal NSC-34 cells\n1556: [Plasmatic glutathione levels and their relationships with clinical and therapeutic features in patients with schizophrenia]\n1559: Regulation of hepatic glutathione metabolism and its role in hepatotoxicity\n1570: Mitochondrial glutathione content determines the rate of liver regeneration after partial hepatectomy in eu- and hypothyroid rats\n1581: Comparison of inhibitory effects between acetaminophen-glutathione conjugate and reduced glutathione in human glutathione reductase\n1588: Glutathione synthesis in normal liver and in Yoshida AH-130 hepatoma\n1607: Mechanism of glutathione transferase P1-1-catalyzed activation of the prodrug canfosfamide (TLK286, TELCYTA)\n1615: Glutathione prevents ethanol induced gastric mucosal damage and depletion of sulfhydryl compounds in humans\n1622: The effects of 3 weeks of oral glutathione supplementation on whole body insulin sensitivity in obese males with and without type 2 diabetes: a randomized trial\n1628: Studies on the fate of the glutathione and cysteine conjugates of acetaminophen in mice\n1639: Radioprotection by glutathione ester: transport of glutathione ester into human lymphoid cells and fibroblasts\n1642: Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity\n1645: p-aminophenol nephrotoxicity: biosynthesis of toxic glutathione conjugates\n1650: Structure of a glutathione conjugate bound to the active site of aldose reductase\n1652: Transport of glutathione at blood-brain barrier of the rat: inhibition by glutathione analogs and age-dependence\n1655: Exogenous glutathione increases endurance to muscle effort in mice\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug19_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Tesamorelin\" (also known as \"tesamorelin\"), here are the article titles and their IDs:\n1472: Tesamorelin\n1474: Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy\n1479: Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy\n1481: Tesamorelin improves fat quality independent of changes in fat quantity\n1485: Tesamorelin, a human growth hormone releasing factor analogue\n1487: Tesamorelin\n1491: Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD\n1496: Clinical Review Report: Tesamorelin (Egrifta) [Internet]\n1500: Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach\n1502: Pharmacoeconomic Review Report: Tesamorelin (Egrifta) [Internet]\n1505: Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial\n1509: Spotlight on tesamorelin in HIV-associated lipodystrophy\n1511: Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial\n1514: Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors\n1521: Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects\n1526: Drug evaluation: tesamorelin, a synthetic human growth hormone releasing factor\n1533: Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data\n1534: Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV\n1537: The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV\n1540: Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction\n1543: The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GH\n1549: Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial\n1552: Impact of Tesamorelin, a Growth Hormone-Releasing Factor (GRF) Analogue, on the Pharmacokinetics of Simvastatin and Ritonavir in Healthy Volunteers\n1555: Tesamorelin: a novel therapeutic option for HIV/HAART-associated increased visceral adipose tissue\n1558: Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension\n1561: Population pharmacokinetic and pharmacodynamic analysis of tesamorelin in HIV-infected patients and healthy subjects\n1565: Effects of Tesamorelin on Neurocognitive Impairment in Abdominally Obese Persons with HIV\n1567: Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat\n1569: Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin\n1571: Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation\n1573: Tesamorelin for the treatment of excess abdominal fat in HIV-1-infected patients with lipodystrophy\n1574: Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy\n1578: Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug20_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"S-23\" (also known as \"s-23\"), here are the article titles and their IDs:\n1596: In vitro characterization of S-23 metabolites produced by human liver microsomes, and subsequent application to urine after a controlled oral administration\n1600: Detection of the selective androgen receptor modulator S-23 and its metabolites in equine urine and plasma following oral administration\n1602: Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug21_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Raloxifene\" (also known as \"raloxifene\"), here are the article titles and their IDs:\n1618: Raloxifene\n1621: Raloxifene\n1624: Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start\n1626: Raloxifene has favorable effects on the lipid profile in women explaining its beneficial effect on cardiovascular risk: A meta-analysis of randomized controlled trials\n1627: Estradiol and raloxifene as adjunctive treatment for women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials\n1629: Raloxifene hydrochloride\n1631: The effects of raloxifene on endothelial function and Inflammation in Postmenopausal women: A Meta-analysis of randomized controlled trials\n1633: Raloxifene: a review of its use in postmenopausal osteoporosis\n1635: Raloxifene: cardiovascular considerations\n1637: Raloxifene and its role in breast cancer prevention\n1638: Raloxifene administration enhances retention in an orthodontic relapse model\n1643: [Raloxifene - an unexploited possibility of prevention and treatment of postmenopausal osteoporosis]\n1647: Raloxifene in breast cancer prevention\n1649: Raloxifene potentiates the effect of gefitinib in triple-negative breast cancer cell lines\n1651: Raloxifene for older women: a review of the literature\n1653: Long-term raloxifene for postmenopausal osteoporosis\n1656: Raloxifene use in clinical practice: efficacy and safety\n1658: Review on raloxifene: profile of a selective estrogen receptor modulator\n1660: Cardiovascular effects of raloxifene hydrochloride\n1661: Update on raloxifene: mechanism of action, clinical efficacy, adverse effects, and contraindications\n1662: Raloxifene prevents intracellular invasion of pathogenic bacteria through modulation of cell metabolic pathways\n1663: Novel anti-Acanthamoebic properties of raloxifene sulfonate/sulfamate derivatives\n1664: Age-and Region-Dependent Disposition of Raloxifene in Rats\n1665: Raloxifene Use After Denosumab Discontinuation Partially Attenuates Bone Loss in the Lumbar Spine in Postmenopausal Osteoporosis\n1666: [Raloxifene]\n1667: Raloxifene: a review of its use in the prevention of invasive breast cancer\n1668: Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants\n1670: The use of raloxifene in osteoporosis treatment\n1671: The effect of raloxifene supplementation on blood pressure and Apo-lipoproteins in postmenopausal women: A systematic review and meta-analysis\n1675: Raloxifene, a cannabinoid type-2 receptor inverse agonist, mitigates visual deficits and pathology and modulates microglia after ocular blast\n1677: The NSABP Study of Tamoxifen and Raloxifene (STAR) trial\n1679: Raloxifene: a new choice for treating and preventing osteoporosis\n1683: Review of raloxifene and its clinical applications in osteoporosis\n1687: Combined Raloxifene and Letrozole for Breast Cancer Patients\n1689: Raloxifene: A selective estrogen receptor modulator (SERM) with multiple target system effects\n1693: [Raloxifene (Evista) in the treatment of postmenopausal osteoporosis--the profile of the patient]\n1695: [Raloxifene: a selective modulator of estrogen receptors]\n1698: Raloxifene prevents stress granule dissolution, impairs translational control and promotes cell death during hypoxia in glioblastoma cells\n1700: Raloxifene attenuates oxidative stress and preserves mitochondrial function in astrocytic cells upon glucose deprivation\n1702: Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells\n1705: Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action\n1706: Formulation and Characterization of Raloxifene Nanostructured Lipid Carriers for Permeability and Uptake Enhancement Applications\n1710: Raloxifene potentiates the effect of fluoxetine against maximal electroshock induced seizures in mice\n1712: Mandibular Osteonecrosis Associated With Raloxifene\n1713: The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women\n1716: Raloxifene temporarily reduces arterial stiffness\n1718: Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial\n1721: Benefit-risk assessment of raloxifene in postmenopausal osteoporosis\n1725: Raloxifene nanomicelles reduce the growth of castrate-resistant prostate cancer\n1728: Identification of raloxifene as a novel \u03b1-glucosidase inhibitor using a systematic drug repurposing approach in combination with cross molecular docking-based virtual screening and experimental verification\n1731: Raloxifene improves the ovariectomy-induced impairment in endothelium-dependent vasodilation\n1734: Chitosan-Raloxifene nanoparticle containing doxorubicin as a new double-effect targeting vehicle for breast cancer therapy\n1738: The Interplay of Raloxifene and Sonochemical Bio-Oss in Early Maxillary Sinus Bone Regeneration: A Histological and Immunohistochemical Analysis in Rabbits\n1739: Raloxifene to prevent postmenopausal osteoporosis\n1742: Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta\n1749: Pulmonary delivery alters the disposition of raloxifene in rats\n1756: The potential renoprotective effect of Raloxifene in renal ischemia-reperfusion injury in a male rat model\n1759: Efficacy of Raloxifene as Add-on Therapy on Disease Activity of Postmenopausal Women with Rheumatoid Arthritis: A Double-blind, Randomized, Placebo-controlled Clinical Trial\n1762: Binding of raloxifene to human complement fragment 5a (hC5a): a perspective on cytokine storm and COVID19\n1765: Immersion in Raloxifene does not significantly improve bone toughness or screw pull-out strength in multiple in vitro models\n1768: Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene\n1771: Mechanism of action and preclinical profile of raloxifene, a selective estrogen receptor modulation\n1775: Hypocalcemia induced by raloxifene\n1779: Raloxifene: another selective estrogen modulator\n1781: [Results of international clinical trials with raloxifene]\n1785: Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial\n1788: Raloxifene effects upon the neuronal system controlling sexual receptivity in female rats\n1791: Combined Thermoneutral Housing and Raloxifene Treatment Improves Trabecular Bone Microarchitecture and Strength in Growing Female Mice\n1794: Folic acid-conjugated raloxifene hydrochloride carbon nanotube for targeting breast cancer cells\n1796: Raloxifene and risk for stroke based on the framingham stroke risk score\n1800: Structural features underlying raloxifene's biophysical interaction with bone matrix\n1817: Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial\n1821: Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: contribution of UGT1A1, UGT1A8 and UGT1A9\n1824: Effect of Raloxifene on all-cause mortality\n1827: Novel hydroxyapatite biomaterial covalently linked to raloxifene\n1833: Comparative Pharmacokinetic Profiles of a Novel Low-Dose Micronized Formulation of Raloxifene 45 mg (AD-101) and the Conventional Raloxifene 60 mg in Healthy Subjects\n1840: Raloxifene covalently bonded to titanium implants by interfacing with (3-aminopropyl)-triethoxysilane affects osteoblast-like cell gene expression\n1843: Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial\n1847: Design, synthesis, and biological evaluation of new raloxifene analogues of improved antagonist activity and endometrial safety\n1849: Bioavailability Enhancement of BCS Class II Raloxifene Hydrochloride by Inclusion Complex and Solid Dispersion Techniques\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug22_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Phenibut\" (also known as \"phenibut\"), here are the article titles and their IDs:\n1669: Phenibut (beta-phenyl-GABA): a tranquilizer and nootropic drug\n1672: Phenibut: A drug with one too many \"buts\"\n1674: Phenibut: Review and Pharmacologic Approaches to Treating Withdrawal\n1676: Phenibut (\u03b2-Phenyl-\u03b3-Aminobutyric Acid): an Easily Obtainable \"Dietary Supplement\" With Propensities for Physical Dependence and Addiction\n1678: Clinical Presentations and Treatment of Phenibut Toxicity and Withdrawal: A Systematic Literature Review\n1680: A systematic review of phenibut withdrawal focusing on complications, therapeutic approaches, and single substance versus polysubstance withdrawal\n1681: A Systematic Review of Phenibut Withdrawals\n1684: Quantity of phenibut in dietary supplements before and after FDA warnings\n1690: Phenibut toxicosis in a dog\n1692: Acute phenibut withdrawal: A comprehensive literature review and illustrative case report\n1696: Phenibut dependence\n1697: Safety and Tolerability of the Anxiolytic and Nootropic Drug Phenibut: A Systematic Review of Clinical Trials and Case Reports\n1699: Phenibut, a GABAB Agonist, Detected in a Fatality\n1701: F-phenibut (\u03b2-(4-Fluorophenyl)-GABA), a potent GABABreceptor agonist, activates an outward-rectifying K+current and suppresses the generation of action potentials in mouse cerebellar Purkinje cells\n1703: Chronic Phenibut Use: Symptoms, Severe Withdrawal, and Recovery\n1707: Toxidrome of an Easily Obtainable Nootropic: A Case Report of Phenibut Intoxication and Withdrawal Delirium\n1709: [Phenibut: harmless dietary supplement or dangerous drug?]\n1711: Phenibut Addiction in a Patient with Substance Use Disorder\n1714: Seizure Occurring During Baclofen Monotherapy for Phenibut Withdrawal\n1715: R-phenibut binds to the \u03b12-\u03b4 subunit of voltage-dependent calcium channels and exerts gabapentin-like anti-nociceptive effects\n1717: Management of Phenibut Use Disorder and Withdrawal in a Geriatric Patient\n1723: Phenibut exposures and clinical effects reported to a regional poison center\n1729: Acute Psychosis Associated with Phenibut Ingestion\n1732: Mitochondrial-Protective Effects of R-Phenibut after Experimental Traumatic Brain Injury\n1740: Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity\n1745: Reasons for use and experiences of using phenibut, a mixed methods analysis of online reports\n1748: Phenibut (\u03b2-Phenyl-\u03b3-aminobutyric Acid) Dependence and Management of Withdrawal: Emerging Nootropics of Abuse\n1752: The neuroprotective effects of R-phenibut after focal cerebral ischemia\n1755: Experimental Substantiation of the Use of Phenibut Combinations with Salicylic, Nicotinic, and Glutamic Acids in Cerebral Ischemia\n1758: Comparative pharmacological activity of optical isomers of phenibut\n1764: A Case of Phenibut Directed Detoxification Leading to Toxicity During the COVID-19 Pandemic\n1767: An Unusual Presentation of an Uncommon Drug: A Case Report on Phenibut Overdose\n1770: Acute behavioural disturbance associated with phenibut purchased via an internet supplier\n1773: A Case of Phenibut Withdrawal Management and Detoxification Using Baclofen in the Outpatient Setting\n1778: Phenibutan\u2014an Illegal Food Supplement With Psychotropic Effects and Health Risks\n1783: Purchasing \"Nootropics\" Online: Identification and Quantification of Ingredients in Phenibut-Containing Products\n1787: Effects of Phenibut and Citrocard on Non-Competitive and Competitive Behavior during Provoked Aggression in Animals\n1790: Psychomotor Agitation Non-responsive to Treatment: A Case Report of Phenibut Withdrawal Syndrome\n1792: Quantitative analysis of phenibut in rat brain tissue extracts by liquid chromatography-tandem mass spectrometry\n1798: Back Pedaling on Baclofen: Highlighting Concerns Surrounding Baclofen use in Phenibut Withdrawal\n1801: [Phenibut potentiation of the therapeutic action of antiparkinson agents]\n1802: Effects of the GABA receptor agonist phenibut on behavior and respiration in rabbits in emotionally negative situations\n1805: Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank\n1809: Effect of Phenibut and Glufimet, a Novel Glutamic Acid Derivative, on Respiration of Heart and Brain Mitochondria from Animals Exposed to Stress against the Background of Inducible NO-Synthase Blockade\n1819: Backpedaling on Baclofen: Highlighting Concerns Surrounding Baclofen Use in Phenibut Withdrawal: Letter to the Editor Response\n1822: Case Report of Physiologic Phenibut Dependence Treated With a Phenobarbital Taper in a Patient Being Treated With Buprenorphine\n1828: [Effect of phenibut on the respiratory arrest caused by serotonin]\n1835: Optical isomers of phenibut inhibit [H(3)]-Gabapentin binding in vitro and show activity in animal models of chronic pain\n1838: [Bioequivalence of anvifen and phenibut]\n1842: Telescoped Continuous Flow Synthesis of Optically Active \u03b3-Nitrobutyric Acids as Key Intermediates of Baclofen, Phenibut, and Fluorophenibut\n1844: Inhibition of the Expression of Inducible NO Synthase by Neuroactive Amino Acid Derivatives Phenibut and Glufimet In Vitro and Ex Vivo\n1846: Comparative study of immunocorrective activity of phenibut and its organic salts in experimental immunodeficiency\n1852: [Gravidaprotective action of phenibut in experimental pre-eclampsia]\n1855: [Influence of GABA agonist phenibut on the neuronal activity and interaction in hippocampus and neocortex in emotionally negative situations]\n1858: [Psychotropic effect of phenibut salts and their compositions with organic acids]\n1860: [Effect of GABA receptor agonist phenibut on behavior and respiration of rabbits in the negative emotional situation]\n1863: [Effect of phenibut on interhemispheric transmission in the rat brain]\n1865: [Role of the GABAergic system in the mechanism of the stress-regulating action of phenibut]\n1869: [Comparative study of immunomodulating properties of phenibut and gammoxin]\n1871: NEUROPROTECTIVE ACTION OF PHENIBUT AND NEUROGLUTAM IN EXPERIMENTAL CEREBRAL ISCHEMIA ON THE BACKGROUND OF ALTERED IMMUNOREACTIVITY\n1873: [Effect of phenibut and its composition with nicotinic acid on hemostasis in rats with brain ischemia]\n1874: [NO-DEPENDENT MECHANISM OF THE CARDIOPROTECTIVE ACTION OF PHENIBUT ON STRESS-INDUCED VIOLATION OF CONTRACTILE FUNCTION OF THE HEART]\n1876: [Effect of the GABA derivative phenibut on learning]\n1879: [Effect of phenibut on the content of monoamines, their metabolites, and neurotransmitter amino acids in rat brain structures]\n1880: [Effect of phenibut, obsidan and their combination on the human functional state in hyperthermia]\n1884: [Effects of phenibut on parameters of cerebral hemodynamics in swimmers with dysadaptation syndrome and various types of systemic hemodynamics]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug23_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Telmisartan\" (also known as \"telmisartan\"), here are the article titles and their IDs:\n1720: Effects of telmisartan on metabolic syndrome components: a comprehensive review\n1724: Treatment of proteinuria in dogs with telmisartan: A retrospective study\n1727: Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia\n1730: [Telmisartan in the treatment of hypertensive patients]\n1736: Fenofibrate and Telmisartan in the Management of Abdominal Aortic Aneurysm\n1741: Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments\n1744: Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double-blind, multicenter, therapeutic confirmatory, phase III clinical trial\n1747: Telmisartan (and/or nitrosamine) - induced occult melanoma: first reported case in world literature\n1750: Telmisartan: just an antihypertensive agent? A literature review\n1751: Telmisartan inhibits microglia-induced neurotoxic A1 astrocyte conversion via PPAR\u03b3-mediated NF-\u03baB/p65 degradation\n1754: Telmisartan-induced sprue-like enteropathy: a case report\n1757: Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial\n1763: Telmisartan prevents high-fat diet-induced neurovascular impairments and reduces anxiety-like behavior\n1766: Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials\n1769: Telmisartan anti-cancer activities mechanism through targeting N-cadherin by mimicking ADH-1 function\n1772: Telmisartan-Induced Myotoxicity in Patients with Essential Hypertension\n1776: Telmisartan is the most effective ARB to increase adiponectin via PPAR\u03b1 in adipocytes\n1780: Telmisartan Reduces Axon Degeneration in Mice With Experimental Glaucoma\n1786: Telmisartan ameliorates LPS-induced pneumonia in rats through regulation of the PPAR\u03b3/NF-\u03baB pathway\n1789: Telmisartan loading thermosensitive hydrogel repairs gut epithelial barrier for alleviating inflammatory bowel disease\n1793: Telmisartan Protects Auditory Hair Cells from Gentamicin-Induced Toxicity in vitro\n1797: Effect of telmisartan on an experimental model of periodontitis in mice\n1803: An insight into the role of telmisartan as PPAR-\u03b3/\u03b1 dual activator in the management of nonalcoholic fatty liver disease\n1807: Telmisartan cardioprotects from the ischaemic/hypoxic damage through a miR-1-dependent pathway\n1810: Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertension\n1815: Antihypertensive effect of telmisartan versus perindopril in hypertensive patients\n1818: MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells\n1820: Telmisartan attenuates human glioblastoma cells proliferation and oncogenicity by inducing the lipid oxidation\n1823: Telmisartan Protects Against Aluminum-Induced Alzheimer-like Pathological Changes in Rats\n1826: Telmisartan Improves Insulin Resistance: A Meta-Analysis\n1829: Telmisartan Protects Mitochondrial Function, Gait, and Neuronal Apoptosis by Activating the Akt/GSK3\u03b2/PGC1\u03b1 Pathway in an MPTP-Induced Mouse Model of Parkinson's Disease\n1832: Telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model\n1834: Telmisartan improves myocardial remodeling by inhibiting leptin autocrine activity and activating PPAR\u03b3\n1837: Telmisartan ameliorates A\u03b2 oligomer-induced inflammation via PPAR\u03b3/PTEN pathway in BV2 microglial cells\n1841: Clinical pharmacology of telmisartan:\n1845: Telmisartan attenuates obesity-induced insulin resistance via suppression of AMPK mediated ER stress\n1848: Telmisartan induces a specific gut microbiota signature which may mediate its antiobesity effect\n1851: Telmisartan Nanosuspension for Inhaled Therapy of COVID-19 Lung Disease and Other Respiratory Infections\n1853: Improving effects of telmisartan on spermatogenic disorder induced by fractionated low-dose irradiation in mice\n1854: Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial\n1856: Telmisartan Is a Promising Agent for Managing Neuropathic Pain and Delaying Opioid Analgesic Tolerance in Rats\n1857: Telmisartan attenuates hydrogen peroxide-induced apoptosis in differentiated PC12 cells\n1859: Evaluation of oral telmisartan administration as a suppression test for diagnosis of primary hyperaldosteronism in cats\n1862: Telmisartan Plus Amlodipine as the Preferred Initial Combination in Newly Diagnosed Indian Patients with Hypertension: An Expert Consensus Statements\n1864: Telmisartan induces browning of fully differentiated white adipocytes via M2 macrophage polarization\n1866: A new Febuxostat-Telmisartan Drug-Drug Cocrystal for Gout-Hypertension Combination Therapy\n1868: Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19\n1870: Telmisartan prevents development of obesity and normalizes hypothalamic lipid droplets\n1872: Telmisartan Restricts Chikungunya Virus InfectionIn VitroandIn Vivothrough the AT1/PPAR-\u03b3/MAPKs Pathways\n1875: Telmisartan Mitigates High-Glucose-Induced Injury in Renal Glomerular Endothelial Cells (rGECs) and Albuminuria in Diabetes Mice\n1877: Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan\n1878: Telmisartan Influences the Antiproliferative Activity of Linoleic Acid in Human Colon Cancer Cells\n1881: Telmisartan as an add-on treatment for dogs with refractory idiopathic epilepsy: a nonrandomized, uncontrolled, open-label clinical trial\n1883: Telmisartan neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: Cross talk between PPAR-\u03b3 and PI3K/Akt/GSK-3\u03b2 pathway\n1885: Immunomodulation of Telmisartan-Loaded PCL/PVP Scaffolds on Macrophages Promotes Endogenous Bone Regeneration\n1886: Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial\n1887: Telmisartan ameliorates nephropathy and restores the hippo pathway in rats with metabolic syndrome\n1888: Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study\n1889: Electrospun orally disintegrating film formulation of telmisartan\n1890: Telmisartan relieves liver fibrosis and portal hypertension by improving vascular remodeling and sinusoidal dysfunction\n1891: Telmisartan/hydrochlorothiazide-induced nevus-associated cutaneous melanoma: first report in the medical literature\n1892: Telmisartan and captopril ameliorate pregabalin-induced heart failure in rats\n1893: Telmisartan Attenuates Uric Acid-Induced Epithelial-Mesenchymal Transition in Renal Tubular Cells\n1894: Three-Year Cardiovascular Outcomes of Telmisartan in Patients With Hypertension: An Electronic Health Record-Based Cohort Study\n1895: Telmisartan-Loaded Lactosylated Chitosan Nanoparticles as a Liver Specific Delivery System: Synthesis, Optimization and Targeting Efficiency\n1896: Intraperitoneal Administration of Telmisartan Prevents Postsurgical Adhesion Band Formation\n1897: Single-dose pharmacokinetics of telmisartan oral solution and effect of feeding in dogs\n1898: Triple Therapy with Telmisartan, Amlodipine, and Rosuvastatin (TAR) Versus Telmisartan/Amlodipine (TA) and Telmisartan/Rosuvastatin (TR) Combinations in Hypertension and Dyslipidemia: A Systematic Review and Meta-analysis\n1899: The influence of telmisartan on metformin pharmacokinetics and pharmacodynamics\n1900: Pre-clinical and clinical experience of telmisartan in cardiac remodelling\n1901: Telmisartan Exerts Cytotoxicity in Scirrhous Gastric Cancer Cells by Inducing G0/G1Cell Cycle Arrest\n1903: Telmisartan-Induced Cytotoxicity via G2/M Phase Arrest in Renal Cell Carcinoma Cell Lines\n1905: The telmisartan programme of research tO show Telmisartan End-organ proteCTION (PROTECTION) programme\n1907: Risk of myocardial infarction, heart failure, and cerebrovascular disease with the use of valsartan, losartan, irbesartan, and telmisartan in patients\n1911: Telmisartan Inhibits the NLRP3 Inflammasome by Activating the PI3K Pathway in Neural Stem Cells Injured by Oxygen-Glucose Deprivation\n1913: Telmisartan mitigates lipopolysaccharide (LPS)-induced production of mucin 5AC (MUC5AC) through increasing suppressor of cytokine signaling 1 (SOCS1)\n1915: A Novel Hybrid of Telmisartan and Borneol Ameliorates Neuroinflammation and White Matter Injury in Ischemic Stroke Through ATF3/CH25H Axis\n1917: Telmisartan Inhibits Nitric Oxide Production and Vessel Relaxation via Protein Phosphatase 2A-mediated Endothelial NO Synthase-Ser1179Dephosphorylation\n1919: Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats\n1920: A meta-analysis of randomized trials of telmisartan versus active controls for insulin resistance in hypertensive patients\n1921: Telmisartan: An angiotensin receptor blocker regulates osteoclastogenesis via inhibition of the ERK triggering in osteoporotic male rats\n1922: [Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review]\n1923: Telmisartan attenuates kidney apoptosis and autophagy-related protein expression levels in an intermittent hypoxia mouse model\n1924: Telmisartan use in rats with preexisting osteoporotics bone disorders increases bone microarchitecture alterations via PPAR\u03b3\n1925: [Telmisartan chronotherapy and its influence on the indicators of the daily profile blood pressure]\n1926: Telmisartan Plus S-Amlodipine Single-Pill Combination Therapy is Safe and Effective in Patients with Hypertension from Large-Scale Nationwide Surveillance Data in Korea (NOVEL) Study\n1927: Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial\n1928: Telmisartan Facilitates the Anticancer Effects of CARP-1 Functional Mimetic and Sorafenib in Rociletinib Resistant Non-small Cell Lung Cancer\n1929: Evaluation of novobiocin and telmisartan for anti-CHIKV activity\n1930: Effect of Telmisartan on Arsenic-Induced (Sub-chronic) Perturbations in Redox Homeostasis, Pro-inflammatory Cascade and Aortic Dysfunction in Wistar Rats\n1931: Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target-mediated drug disposition and OATP1B3-mediated hepatic uptake in a physiologically based model\n1932: Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPAR\u03b3 Activation\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug24_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"CJC-1295\" (also known as \"cjc-1295\"), here are the article titles and their IDs:\n1902: Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults\n1906: Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions\n1910: Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation\n1912: Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse\n1914: Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog\n1916: Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog\n1918: Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug25_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Bromantane\" (also known as \"bromantane\"), here are the article titles and their IDs:\n1933: Toxic effect of single treatment with bromantane on neurological status of experimental animals\n1934: [Effect of bromantane on the rat neurologic status in two month course]\n1935: [The characteristics of the neuropsychotropic activity of bromantane in laboratory animals]\n1936: [Study of heat-protective effects of bromantane at various levels of overheating]\n1937: [A quantitative pharmaco-electroencephalographic analysis of the action of bromantane]\n1938: [An acute toxicity study of bromantane]\n1939: [Effects of bromantane and sidnocarb on long-term operant conditioning and its vegetative correlates in rats]\n1940: [The neuro- and psychophysiological effects of bromantane]\n1941: [The effect of bromantane on the erythro- and leukocytic profile of the peripheral blood in rats]\n1943: [The effect of bromantane on the physical work capacity of laboratory animals]\n1944: [The effect of bromantane on the dopamin- and serotoninergic systems of the rat brain]\n1946: [The effect of bromantane on the behavior of inbred mouse strains with different phenotypes of emotional stress reaction]\n1949: [Complex evaluation of the effect of bromantane on animal behavior]\n1950: [The effect of bromantane on the cardiovascular and sympathetic-adrenal systems in animals]\n1951: [The effect of the actoprotector preparation bromantane on the postnatal development of rat pups]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug28_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Human Menopausal Gonadotropin\" (also known as \"hmg\"), here are the article titles and their IDs:\n1958: HMG CoA reductase inhibitors\n1959: Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management\n1963: Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy\n1964: Comparative tolerability of the HMG-CoA reductase inhibitors\n1965: The use of HMG-CoA reductase inhibitors to prevent accelerated graft atherosclerosis in heart transplant patients\n1973: Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis\n1976: HMG improves IVF outcome in patients with high basal FSH/LH ratio: a preliminary study\n1977: Modified hMG stimulated: an effective option in endometrial preparation for frozen-thawed embryo transfer in patients with normal menstrual cycles\n1981: Pregnancy And Neonatal Outcomes Of hMG Stimulation With Or Without Letrozole In Endometrial Preparation For Frozen-Thawed Embryo Transfer In Ovulatory Women: A Large Retrospective Cohort Study\n1986: Antibodies to HMG proteins in patients with drug-induced autoimmunity\n1992: HMG-CoA-reductase inhibitors and neuropathy: reports to the Netherlands Pharmacovigilance Centre\n1998: Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen\n2003: Sequential clomiphene citrate/hMG versus hMG for ovulation induction in clomiphene citrate-resistant women\n2014: Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists--a randomized study\n2019: Targeted delivery of Chil3/Chil4 siRNA to alveolar macrophages using ternary complexes composed of HMG and oligoarginine micelles\n2022: Comparing three superovulation protocols in dromedary camels: FSH, eCG-FSH and hMG\n2054: Expression of HMG-CoA reductase in human coronary atherosclerotic plaques and relationship to plaque destabilisation\n2060: Modulation of HMG-N2 binding to chromatin by butyrate-induced acetylation in human colon adenocarcinoma cells\n2069: Cumulative Live Birth Rates Following Stimulation With Corifollitropin Alfa Compared With hp-hMG in a GnRH Antagonist Protocol in Poor Ovarian Responders\n2071: A modified hMG-GnRH method for the induction of ovulation in infertile women with severe hypogonadotropic amenorrhea\n2075: Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer\n2082: Recombinant FSH versus HP-HMG for controled ovarian stimulation in intracitoplasmic sperm injection cycles\n2098: Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis\n2111: Comparison of FSH and hMG on ovarian stimulation outcome with a GnRH antagonist protocol in younger and advanced reproductive age women\n2116: Dual function of Ixr1 in transcriptional regulation and recognition of cisplatin-DNA adducts is caused by differential binding through its two HMG-boxes\n2128: Human menopausal gonadotropin versus highly purified-hMG in controlled ovarian hyperstimulation for in-vitro fertilisation: does purity improve outcome?\n2142: ADP-ribosylation of HMG proteins and its modulation by different effectors in the liver of aging rats\n2144: Generic human menopausal gonadotropin (hMG) in place of more costly follicle-stimulating hormone (FSH) for routine ovulation induction\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug29_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Liothyronine\" (also known as \"liothyronine\"), here are the article titles and their IDs:\n1978: Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document\n1980: Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine in Hypothyroidism\n1982: Role of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism\n1984: Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism\n1989: Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design\n1993: Liothyronine prescribing in England: costs versus need\n1995: Combination Levothyroxine + Liothyronine Treatment in Pregnancy\n1997: Randomized double-blind placebo-controlled trial on levothyroxine and liothyronine combination therapy in totally thyroidectomized subjects: the LEVOLIO study\n2001: Liothyronine for hypothyroidism: a candidate for disinvestment or in need of further research? A value of information analysis\n2002: Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement\n2004: Liothyronine use in primary hypothyroidism - current concepts\n2006: REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine\n2008: Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR\n2010: Liothyronine Use in Hypothyroidism and its Effects on Cancer and Mortality\n2011: Liothyronine and levothyroxine prescribing in England: A comprehensive survey and evaluation\n2017: Liothyronine could block the programmed death-ligand 1 (PDL1) activity: an e-Pharmacophore modeling and virtual screening study\n2021: Acute Effects of Liothyronine Administration on Cardiovascular System and Energy Metabolism in Healthy Volunteers\n2023: A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS\n2025: Liothyronine use in a 17 year observational population-based study - the tears study\n2027: Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy: A Randomized Crossover Study\n2031: Extended Absorption of Liothyronine from Poly-Zinc-Liothyronine: Results from a Phase 1, Double-Blind, Randomized, and Controlled Study in Humans\n2034: Effect of Liothyronine Treatment on Dermal Temperature and Activation of Brown Adipose Tissue in Female Hypothyroid Patients: A Randomized Crossover Study\n2036: Preliminary Results of a Double-Blind Randomized Controlled Trial Evaluating the Cardiometabolic Effects of Levothyroxine and Liothyronine Compared to Levothyroxine with Placebo in Athyreotic Low-Risk Thyroid Cancer Patients\n2038: Combined therapy with levothyroxine and liothyronine for hypothyroidism\n2042: Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive Parameters\n2047: Use of Combination of Oral Levothyroxine and Liothyronine in Severe Hypothyroidism With Massive Pericardial Effusion\n2049: Use of liothyronine without levothyroxine in the treatment of mild consumptive hypothyroidism caused by hepatic hemangiomas\n2051: Use of liothyronine (L-T3) as an augmentation therapy for depression during pregnancy\n2053: Heart Failure and Stroke Risks in Users of Liothyronine With or Without Levothyroxine Compared with Levothyroxine Alone: A Propensity Score-Matched Analysis\n2055: Key data from the 2022 European Thyroid Association congress: Treatment of primary hypothyroidism: Levothyroxine alone or a combination of levothyroxine and liothyronine?\n2064: Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial\n2067: Metal Coordinated Poly-Zinc-Liothyronine Provides Stable Circulating Triiodothyronine Levels in Hypothyroid Rats\n2070: Therapeutic effects of oral liothyronine on aluminum phosphide poisoning as an adjuvant therapy: A clinical trial\n2077: Successful treatment of myxedema coma with a combination of levothyroxine and liothyronine\n2091: Sexual function and depressive symptoms in young men with hypothyroidism receiving levothyroxine/liothyronine combination therapy\n2097: Treatment of hypothyroidism with levothyroxine plus liothyronine: a randomized, double-blind, crossover study\n2105: Sexual function and depressive symptoms in young women with hypothyroidism receiving levothyroxine/liothyronine combination therapy: a pilot study\n2107: Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism\n2110: Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone\n2117: Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial\n2120: Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone\n2129: Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine\n2132: Persistent hyperthyrotropinemia in congenital hypothyroidism: successful combination treatment with levothyroxine and liothyronine\n2135: The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug31_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Nebivolol\" (also known as \"nebivolol\"), here are the article titles and their IDs:\n2056: Clinical pharmacokinetics of nebivolol: a systematic review\n2059: Therapeutic Properties of Highly Selective \u03b2-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease\n2062: Nebivolol/Valsartan: A Novel Antihypertensive Fixed-Dose Combination Tablet\n2065: Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)\n2068: Nebivolol in the treatment of arterial hypertension\n2072: Nebivolol/valsartan combination for the treatment of hypertension: a review\n2074: Nebivolol/valsartan: Fixed-dose combination for treatment of hypertension\n2079: Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis\n2081: Does nebivolol have renoprotective action in patients with chronic kidney disease conditions? An integrative review\n2083: Nebivolol: a review\n2086: Effects of nebivolol versus other antihypertensive drugs on the endothelial dysfunction in patients with essential hypertension\n2089: Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker\n2092: A Critical Review of Nebivolol and its Fixed-Dose Combinations in the Treatment of Hypertension\n2096: Nebivolol: a review of its clinical and pharmacological characteristics\n2099: A Review of Nebivolol Pharmacology and Clinical Evidence\n2101: Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors\n2106: Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide\n2108: Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data\n2115: Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design\n2119: Ameliorative effect of nebivolol in doxorubicin-induced cardiotoxicity\n2122: Nebivolol Improves Obesity-Induced Vascular Remodeling by Suppressing NLRP3 Activation\n2124: Nebivolol, an antihypertensive agent, has new application in inhibiting melanoma\n2127: Nebivolol Alleviates Vascular Endothelial Insulin Resistance by Inhibiting Endoplasmic Reticulum Stress\n2130: Effect of nebivolol monotherapy or combination therapy on blood pressure levels in patients with hypertension: an updated systematic review and multilevel meta-analysis of 91 randomized controlled trials\n2133: Nebivolol: a review of its use in the management of hypertension and chronic heart failure\n2137: Nebivolol protects erectile functions compared to Metoprolol in hypertensive men with atherogenic, venogenic, psychogenic erectile dysfunction: A prospective, randomized, cross-over, clinical trial\n2141: Effect of nebivolol on erectile function: a systematic review and meta-analysis of randomized controlled trials\n2143: Nebivolol alleviates liver damage caused by methotrexate via AKT1/Hif1\u03b1/eNOS signaling\n2145: Nebivolol: more than a highly selective Beta blocker\n2146: Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage\n2150: Differential Metabolic Effects of Beta-Blockers: an Updated Systematic Review of Nebivolol\n2155: Role of nebivolol in the control and management of central aortic blood pressure in hypertensive patients\n2156: Nebivolol elicits a neuroprotective effect in the cuprizone model of multiple sclerosis in mice: emphasis on M1/M2 polarization and inhibition of NLRP3 inflammasome activation\n2157: Nebivolol and incident cardiovascular events in hypertensive patients compared with nonvasodilatory beta blockers\n2158: A review of the safety and efficacy of nebivolol in the mildly hypertensive patient\n2159: Nebivolol Ameliorates Cisplatin-Induced Nephrotoxicity in Rats\n2160: Nebivolol in the treatment of chronic heart failure\n2161: Nebivolol in chronic heart failure: current evidence and future perspectives\n2162: Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension\n2163: Nebivolol to attenuate the effects of hyper-homocysteinaemia in rats\n2164: Nebivolol Prevents Up-Regulation of Nox2/NADPH Oxidase and Lipoperoxidation in the Early Stages of Ethanol-Induced Cardiac Toxicity\n2166: Recent advances in the treatment of renal diseases with nebivolol: A literature review\n2167: Nebivolol Induced Hyperkalemia: Case Report\n2168: Nebivolol Increases Nitric Oxide Synthase via \u03b23Adrenergic Receptor in Endothelial Cells Following Exposure to Plasma from Preeclamptic Patients\n2169: Therapeutic Effects of Combination of Nebivolol and Donepezil: Targeting Multifactorial Mechanisms in ALS\n2170: Protective effect of nebivolol on rat ovary exposed to deltamethrin toxicity\n2172: Nebivolol prevents indomethacin-induced gastric ulcer in rats\n2173: Early nebivolol treatment is beneficial in myocardial infarction in rats partly through \u03b23-adrenoceptor remodelling\n2174: Nebivolol hydrochloride and its impurities induce pseudo-allergic reactions via mast cell activation\n2175: Antihypertrophic Effects of Nebivolol on Neonatal Cardiomyocyte Hypertrophy Models\n2176: Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension\n2177: Nebivolol protects against cyclophosphamide-induced nephrotoxicity through modulation of oxidative stress, inflammation, and apoptosis\n2179: Nebivolol ameliorates sepsis-evoked kidney dysfunction by targeting oxidative stress and TGF-\u03b2/Smad/p53 pathway\n2180: Nebivolol attenuates the anticonvulsant action of carbamazepine and phenobarbital against the maximal electroshock-induced seizures in mice\n2181: Nebivolol is more effective than atenolol for blood pressure variability attenuation and target organ damage prevention in L-NAME hypertensive rats\n2182: Stereochemical comparison of nebivolol with other beta-blockers\n2184: Nebivolol has a beneficial effect in monocrotaline-induced pulmonary hypertension\n2187: Nebivolol protects the liver against lipopolysaccharide-induced oxidative stress, inflammation, and endoplasmic reticulum-related apoptosis through Chop and Bip/GRP78 signaling\n2189: Antihypertensive Efficacy Of Nebivolol And Low Dose Spironolactone In Patients With Resistant Hypertension\n2191: [Nebivolol: the first vasodilatory beta-blocker with a beta3-adrenergic agonist activity]\n2193: Nebivolol-Loaded Microsponge Gel for Healing of Diabetic Wound\n2197: Nebivolol prevents redox imbalance and attenuates bladder dysfunction induced by cyclophosphamide in mice\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug32_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Piracetam\" (also known as \"piracetam\"), here are the article titles and their IDs:\n2183: Presence of Piracetam in Cognitive Enhancement Dietary Supplements\n2185: Cognitive effects of piracetam in adults with memory impairment: A systematic review and meta-analysis\n2188: Piracetam and other structurally related nootropics\n2190: Piracetam in acute stroke: a systematic review\n2192: Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders\n2194: Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders\n2198: Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles\n2201: Docosahexaenoic Acid Plus Piracetam Versus Piracetam Alone for Treatment of Breath-Holding Spells in Children: A Randomized Clinical Trial\n2210: Effect of organic acids on the solid-state polymorphic phase transformation of piracetam\n2213: Effect of Piracetam and Iron Treatment on Heart Rate Variability in Patients With Breath-Holding Spell\n2239: The effect of piracetam on volunteers in a low-pressure tank\n2243: [Therapeutic effect and mechanism of piracetam for the treatment of spinal cord injury in rats through MAPK pathway]\n2286: [Clinical use of piracetam in chronic alcoholism and its complications predelirium and delirium]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug33_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Pramipexole\" (also known as \"pramipexole\"), here are the article titles and their IDs:\n2195: Comparison of pramipexole versus ropinirole in the treatment of Parkinson's disease\n2196: Classics in Chemical Neuroscience: Pramipexole\n2271: Pramipexole improves depression-like behavior in diabetes mellitus with depression rats by inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing impaired neuroplasticity\n2281: Pramipexole protects against diabetic neuropathy: Effect on oxidative stress, TLR4/IRAK-1/TRAF-6/NF-\u03baB and downstream inflammatory mediators\n2311: Three paradoxes related to the mode of action of pramipexole: The path from D2/D3 dopamine receptor stimulation to modification of dopamine-modulated functions\n2323: Treating activated regulatory T cells with pramipexole protects human dopaminergic neurons from 6-OHDA-induced degeneration\n2324: Pramipexole restores behavioral inhibition in highly impulsive rats through a paradoxical modulation of frontostriatal networks\n2358: Pramipexole decreases allodynia and hyperalgesia via NF-\u03baB in astrocytes in rats with Parkinson's disease\n2363: Pramipexole in patients with early Parkinson's disease\n2387: Pramipexole effects on startle gating in rats and normal men\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug34_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Semax\" (also known as \"semax\"), here are the article titles and their IDs:\n2327: Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats\n2329: Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models\n2336: Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion\n2346: [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]\n2368: [The Peptide Drug ACTH(4-7)PGP (Semax) Suppresses mRNA Transcripts Encoding Proinflammatory Mediators Induced by Reversible Ischemia of the Rat Brain]\n2402: Morphofunctional State of the Large Intestine in Rats under Conditions of Restraint Stress and Administration of Peptide ACTH(4-7)-PGP (Semax)\n2406: [Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)]\n2476: [Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug36_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Selank\" (also known as \"selank\"), here are the article titles and their IDs:\n2384: Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats\n2390: Effect of Selank on Morphological Parameters of Rat Liver in Chronic Foot-Shock Stress\n2392: Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats\n2401: Effect of Selank on Spontaneous Synaptic Activity of Rat Hippocampal CA1 Neurons\n2403: Effect of Selank on Functional State of Rat Hepatocytes under Conditions of Restraint Stress\n2414: State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank Treatment\n2416: Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank\n2462: [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug37_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Noopept\" (also known as \"noopept\"), here are the article titles and their IDs:\n2458: Effects of noopept on ocular, pancreatic and renal histopathology in streptozotocin induced prepubertal diabetic rats\n2466: Noopept Attenuates Diabetes-Mediated Neuropathic Pain and Oxidative Hippocampal Neurotoxicity via Inhibition of TRPV1 Channel in Rats\n2492: [Noopept in the treatment of mild cognitive impairment in patients with stroke]\n2495: Intranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats\n2498: Effect of nootropic dipeptide noopept on CA1 pyramidal neurons involves \u03b17AChRs on interneurons in hippocampal slices from rat\n2519: Physicochemical and structural analysis of N-phenylacetyl-L-prolylglycine ethyl ester (Noopept) - An active pharmaceutical ingredient with nootropic activity\n2521: QbD-driven development of dissolving microneedle patch loaded with ultradeformable liposomes encapsulated Noopept: Exploring a patient friendly, once-daily option to manage dementia\n2534: [Clinical and electroencephalographic characteristic of noopept in patients with mild cognitive impairment of posttraumatic and vascular origin]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug40_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"MOTS-c\" (also known as \"mots-c\"), here are the article titles and their IDs:\n2587: Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 Deubiquitination\n2598: MOTS-c modulates skeletal muscle function by directly binding and activating CK2\n2623: Mitochondria-encoded peptide MOTS-c participates in plasma membrane repair by facilitating the translocation of TRIM72 to membrane\n2633: MOTS-c regulates the ROS/TXNIP/NLRP3 pathway to alleviate diabetic cardiomyopathy\n2733: Could MOTS-C Levels in Children with Type 1 Diabetes Mellitus Be an \u0130ndicator for Early Diabetic Kidney Disease?\n2739: Pyrroloquinoline Quinone Alleviates Mitochondria Damage in Radiation-Induced Lung Injury in a MOTS-c-Dependent Manner\n2744: MOTS-c Impact on Muscle Cell Differentiation and Metabolism Across Fiber Types\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug41_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"deltasleep-inducingpeptide\" (also known as \"deltasleep-inducingpeptide\"), here are the article titles and their IDs:\n2594: The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep\n2600: [Interhemispheric interaction in the rabbit after administration of delta-sleep-inducing-peptide]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug42_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Letrozole\" (also known as \"letrozole\"), here are the article titles and their IDs:\n2613: Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer\n2630: A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study\n2654: The Effectiveness of Letrozole Alone or in Combination with Methotrexate in the Management of Ectopic Pregnancy, A Systematic Review and Meta-Analysis\n2789: Effects of letrozole on serum estradiol and estrone in postmenopausal breast cancer patients and tolerability of treatment: a prospective trial using a highly sensitive LC-MS/MS (liquid chromatography-tandem mass spectrometry) method for estrogen measurement\n2798: Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5\n2836: Impact of letrozole co-treatment in an antagonist protocol for IVF/ICSI: a retrospective study\n2854: Ribociclib plus letrozole in patients with hormone receptor-positive, HER2-negative advanced breast cancer with no prior endocrine therapy: subgroup safety analysis from the phase 3b CompLEEment-1 trial\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug43_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"L-carnitine\" (also known as \"l-carnitine\"), here are the article titles and their IDs:\n2684: Effect of l-Carnitine Supplementation on Osteoarthritis: A Systematic Review\n2707: l-Carnitine relieves cachexia-related skeletal muscle fibrosis by inducing deltex E3 ubiquitin ligase 3L to negatively regulate the Runx2/COL1A1 axis\n2762: Potential utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction-associated steatohepatitis\n2770: l-Carnitine pretreatment ameliorates heat stress-induced acute kidney injury by restoring mitochondrial function of tubular cells\n2834: Dietary L-carnitine supplementation modifies blood parameters of mid-lactating dairy cows during standardized lipopolysaccharide-induced inflammation\n2869: L-carnitine improves glucose disposal in type 2 diabetic patients\n2884: The effects of L-carnitine supplementation on performance during interval swimming\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug44_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"GHRP-6\" (also known as \"ghrp-6\"), here are the article titles and their IDs:\n2823: Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms\n2840: GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP\n2847: Effects of ghrelin, GH-releasing peptide-6 (GHRP-6) and GHRH on GH, ACTH and cortisol release in hyperthyroidism before and after treatment\n2855: Ghrelin and GHRP-6-induced ACTH and cortisol release in thyrotoxicosis\n2859: Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers\n2872: Inhibition of ghrelin activity by the receptor antagonist [D-Lys3]-GHRP-6 enhances hepatic fatty acid oxidation and gluconeogenesis in a growing pig model\n2936: Changes in Locomotor Activity Observed During Acute Nicotine Withdrawal Can Be Attenuated by Ghrelin and GHRP-6 in Rats\n2945: Growth hormone response to GHRH + GHRP-6 in type 2 diabetes during euglycemic and hyperglycemic clamp\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug46_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Follistatin-344\" (also known as \"follistatin-344\"), here are the article titles and their IDs:\n2924: Central serous chorioretinopathy associated with high-dose follistatin-344: a retrospective case series\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug49_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Oxiracetam\" (also known as \"oxiracetam\"), here are the article titles and their IDs:\n2963: Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial\n2977: Effect of l-oxiracetam and oxiracetam on memory and cognitive impairment in mild-to-moderate traumatic brain injury patients: Study protocol for a randomized controlled trial\n2995: Oxiracetam in dementia: a double-blind, placebo-controlled study\n3011: Safety, tolerability, and pharmacokinetics of oral (S)-oxiracetam in Chinese healthy volunteers: A randomized, double-blind, controlled phase I study\n3016: Development and validation of a chiral UPLC-MS/MS method for quantifying S-Oxiracetam and R-Oxiracetam in human plasma, urine and feces: Application to a phase-I clinical pharmacokinetic study\n3041: Treatment trial of oxiracetam in Alzheimer's disease\n3070: Effectiveness of oxiracetam therapy in the treatment of cognitive deficiencies secondary to primary degenerative dementia\n3083: Organic brain syndrome treated with oxiracetam. A double-blind randomized controlled trial\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug52_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Levothyroxine\" (also known as \"levothyroxine\"), here are the article titles and their IDs:\n3116: Levothyroxine Dosing for Thyroid-Stimulating Hormone Suppression in Patients with Differentiated Thyroid Cancer after Total Thyroidectomy\n3144: Thyroid Hormone Homeostasis in Levothyroxine-treated Patients: Findings From ELSA-Brasil\n3148: Levothyroxine bioequivalence\n3156: A review of the safety of triiodothyronine in combination with levothyroxine for the management of hypothyroidism\n3170: Therapeutic efficacy and patient compliance of levothyroxine liquid and softgel formulations taken with meals: a systematic review\n3211: Effect of oral semaglutide on the pharmacokinetics of thyroxine after dosing of levothyroxine and the influence of co-administered tablets on the pharmacokinetics of oral semaglutide in healthy subjects: an open-label, one-sequence crossover, single-center, multiple-dose, two-part trial\n3214: Phase II Clinical Trial of Intravenous Levothyroxine to Mitigate Pharyngocutaneous Fistula in Euthyroid Patients Undergoing Salvage Laryngectomy\n3226: Levothyroxine sodium tablets: chemical equivalence and bioequivalence\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug53_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Synephrine\" (also known as \"synephrine\"), here are the article titles and their IDs:\n3178: Synephrine, as a scavenger and promoter, cooperates with hesperidin to reduce acrolein levels\n3203: Synephrine Inhibits Oxidative Stress and H2O2-Induced Premature Senescence\n3234: Transcriptome analysis ofCitrus AurantiumL. to study synephrine biosynthesis during developmental stages\n3258: Scavenging Glyoxal and Methylglyoxal by Synephrine Alone or in Combination with Neohesperidin at High Temperatures\n3265: Scavenging Glyoxal and Methylglyoxal by Synephrine and Neohesperidin from Flowers ofCitrus aurantiumL. var.amaraEngl. in Mice and Humans\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug54_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"NAD+\" (also known as \"nad+\"), here are the article titles and their IDs:\n3206: NAD+-Increasing Strategies to Improve Cardiometabolic Health?\n3208: Host NAD+ metabolism and infections: therapeutic implications\n3210: NAD+ and NADH in neuronal death\n3213: NAD+ and vitamin B3: from metabolism to therapies\n3218: The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways\n3228: [The pathophysiological importance and therapeutic potential of NAD+ biosynthesis in age-related diseases]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug55_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Bemethyl\" (also known as \"bemethyl\"), here are the article titles and their IDs:\n3273: [Effects of bemethyl, ethomersol, and yakton on the liver regeneration after partial hepatectomy]\n3274: [Structural analysis of the functional status of the brain as affected by bemethyl using pattern recognition theory]\n3275: [Effect of bemethyl on the glutathione system in the rat liver in acute hypoxia]\n3276: [Effect of bemethyl on cytochrome P-450-dependent monoxygenases in the human liver and lymphocytes]\n3278: [Membrane mechanisms of effects of antihypoxic agents bemethyl and almide on neurons of Mollusca]\n3279: [Features of the effect of bemethyl on glycogen metabolism in hepatocytes of pathological changed human liver]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug59_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"RU58841\" (also known as \"ru58841\"), here are the article titles and their IDs:\n3289: Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques\n3292: A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice\n3296: RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia\n3300: Local inhibition of sebaceous gland growth by topically applied RU 58841\n3303: RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug57_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"L-theanine\" (also known as \"l-theanine\"), here are the article titles and their IDs:\n3297: L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial\n3337: The effects of L-theanine supplementation on the outcomes of patients with mental disorders: a systematic review\n3342: l-Theanine Alleviates Ulcerative Colitis by Regulating Colon Immunity via the Gut Microbiota in an MHC-II-Dependent Manner\n3349: L-theanine alleviates myocardial ischemia/reperfusion injury by suppressing oxidative stress and apoptosis through activation of the JAK2/STAT3 pathway in mice\n3367: Impact of L-theanine and L-tyrosine on markers of stress and cognitive performance in response to a virtual reality based active shooter training drill\n3450: l-theanine: From tea leaf to trending supplement - does the science match the hype for brain health and relaxation?\n3467: Effect of L-theanine on glutamatergic function in patients with schizophrenia\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug58_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"TUDCA\" (also known as \"tudca\"), here are the article titles and their IDs:\n3312: TUDCA inhibits EV71 replication by regulating ER stress signaling pathway and suppressing autophagy\n3321: A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial\n3325: TUDCA modulates drug bioavailability to regulate resistance to acute ER stress inSaccharomyces cerevisiae\n3343: Possible Role of Tauroursodeoxycholic Acid (TUDCA) and Antibiotic Administration in Modulating Human Gut Microbiota in Home Enteral Nutrition Therapy for the Elderly: A Case Report\n3348: Tauroursodeoxycholic Acid (TUDCA) Relieves Streptozotocin (STZ)-Induced Diabetic Rat Model via Modulation of Lipotoxicity, Oxidative Stress, Inflammation, and Apoptosis\n3388: Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease\n3414: Promoting longevity in aged liver through NLRP3 inflammasome inhibition using tauroursodeoxycholic acid (TUDCA) and SCD probiotics\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug60_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Pregnenolone\" (also known as \"pregnenolone\"), here are the article titles and their IDs:\n3403: Pregnenolone sulfate induces transcriptional and immunoregulatory effects on T cells\n3434: Pregnenolone for cognition and mood in dual diagnosis patients\n3464: CLICK-chemoproteomics and molecular dynamics simulation reveals pregnenolone targets and their binding conformations in Th2 cells\n3491: Rescuing tri-heteromeric NMDA receptor function: the potential of pregnenolone-sulfate in loss-of-function GRIN2B variants\n3509: Advances in steroid research from the pioneering neurosteroid concept to metabolomics: New insights into pregnenolone function\n3518: The effect of pregnenolone sulfate on uterine contractility\n3534: Brief report: an open-label study of the neurosteroid pregnenolone in adults with autism spectrum disorder\n3538: Assessing the Inhibitory Potential of Pregnenolone Sulfate on Pentraxin 3 in Diabetic Kidney Disease: A Molecular Docking and Simulation Study\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug61_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"GHK-Cu\" (also known as \"ghk-cu\"), here are the article titles and their IDs:\n3500: Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests\n3525: Polyaspartic acid, 2-acrylamido-2-Methyl propane sulfonic acid and sodium alginate based biocompatible stimuli responsive polymer gel for controlled release of GHK-Cu peptide for wound healing\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug62_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"DMHA\" (also known as \"dmha\"), here are the article titles and their IDs:\n3520: A novel amidohydrolase (DmhA) from Sphingomonas sp. that can hydrolyze the organophosphorus pesticide dimethoate to dimethoate carboxylic acid and methylamine\n3524: Wild-type p53 protein potentiates phototoxicity of 2-BA-2-DMHA in HT29 cells expressing endogenous mutant p53\n3529: A novel photosensitizer, 2-butylamino-2-demethoxy-hypocrellin A (2-BA-2-DMHA). 1. Synthesis of 2-BA-2-DMHA and its phototoxicity to MGC803 cells\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug64_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Sunifiram\" (also known as \"sunifiram\"), here are the article titles and their IDs:\n3553: Novel Sunifiram-carbamate hybrids as potential dual acetylcholinesterase inhibitor and NMDAR co-agonist: simulation-guided analogue design and pharmacological screening\n3555: DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer\n3556: Novel nootropic drug sunifiram improves cognitive deficits via CaM kinase II and protein kinase C activation in olfactory bulbectomized mice\n3557: Novel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine-binding site of N-methyl-D-aspartate receptor\n3558: Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers\n3559: Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators\n3561: Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs\n3563: AMPA-receptor activation is involved in the antiamnesic effect of DM 232 (unifiram) and DM 235 (sunifiram)\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug65_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Kisspeptin-10\" (also known as \"kisspeptin-10\"), here are the article titles and their IDs:\n3560: Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of Src\n3562: Kisspeptin-10 increases collagen content in the myocardium by focal adhesion kinase activity\n3583: Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men\n3588: Kisspeptin-10 Improves Testicular Redox Status but Does Not Alter the Unfolded Protein Response (UPR) That Is Downregulated by Hypothyroidism in a Rat Model\n3620: The antidepressant-like effects of kisspeptin-10 are reversed by kisspeptin antagonist peptide 234 in male rats\n3634: Intraperitoneal administration of kisspeptin-10 modulates follicle maturation, gonadal steroids, calcium and metabolites in Sterlet sturgeon, Acipenser ruthenus\n3642: Age-dependent changes in the reproductive axis responsiveness to kisspeptin-10 administration in healthy men\n3658: Author Correction: Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of Src\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug67_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"MGF\" (also known as \"mgf\"), here are the article titles and their IDs:\n3650: The Effects of IGF1 and MGF on Neural Stem Cells in Hypoxic Conditions\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug69_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"KPV\" (also known as \"kpv\"), here are the article titles and their IDs:\n3664: A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon\n3667: KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy\n3669: Self-Cross-Linked Hydrogel of Cysteamine-Grafted \u03b3-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Rats\n3672: In situmucoadhesive hydrogel capturing tripeptide KPV: the anti-inflammatory, antibacterial and repairing effect on chemotherapy-induced oral mucositis\n3675: Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis\n3679: Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug71_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Myostatin\" (also known as \"myostatin\"), here are the article titles and their IDs:\n3740: Myostatin and the Heart\n3750: Myostatin's marvels: From muscle regulator to diverse implications in health and disease\n3790: Fecal transplant from myostatin deletion pigs positively impacts the gut-muscle axis\n3883: Myostatin Changes in Females with UI after Magnetic Stimulation: A Quasi-Experimental Study\n3889: Licochalcone A and B enhance muscle proliferation and differentiation by regulating Myostatin\n3895: Myostatin serum levels depends on age and diet in athletic and no athletic dogs\n3965: Inactivation of Myostatin Delays Senescence via TREX1-SASP in Bovine Skeletal Muscle Cells\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug70_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"7,8-dihydroxyflavone\" (also known as \"7,8-dihydroxyflavone\"), here are the article titles and their IDs:\n3775: 7,8-Dihydroxyflavone is a direct inhibitor of human and murine pyridoxal phosphatase\n3822: 7, 8-dihydroxyflavone Ameliorates Cholinergic Dysfunction, Inflammation, Oxidative Stress, and Apoptosis in a Rat Model of Vascular Dementia\n3830: Investigating 7,8-Dihydroxyflavone to combat maternal immune activation effects on offspring gene expression and behaviour\n3856: Impact of dietary plant flavonoids on 7,8-dihydroxyflavone transepithelial transport in human intestinal Caco-2 cells\n3891: 7,8-Dihydroxyflavone ameliorates cognitive impairment induced by repeated neonatal sevoflurane exposures in mice through increasing tau O-GlcNAcylation\n3937: 7,8-dihydroxyflavone displayed antioxidant effect through activating HO-1 expression and inhibiting caspase-3/PARP activation in RAW264.7 cells\n3951: 7,8-Dihydroxy Flavone Induces Apoptosis via Upregulation of Caspase-3 in Human Hepatocarcinoma Cell\n3954: Post-injury treatment with 7,8-dihydroxyflavone attenuates white matter pathology in aged mice following focal traumatic brain injury\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug73_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Amentoflavone\" (also known as \"amentoflavone\"), here are the article titles and their IDs:\n3865: Amentoflavone for treating cardiocerebrovascular diseases and neurological disorders\n3930: Amentoflavone maintaining extracellular matrix homeostasis and inhibiting subchondral bone loss in osteoarthritis by inhibiting ERK, JNK and NF-\u03baB signaling pathways\n3963: Amentoflavone alleviated cartilage injury and inflammatory response of knee osteoarthritis through PTGS2\n3970: Amentoflavone fromSelaginella tamariscinainhibits SARS-CoV-2 RNA-dependent RNA polymerase\n3996: Antiviral Effect of Amentoflavone Against Influenza Viruses\n3998: Amentoflavone Induces Ferroptosis to Alleviate Proliferation, Migration, Invasion and Inflammation in Rheumatoid Arthritis Fibroblast-like Synoviocytes by Inhibiting PIN1\n4026: Amentoflavone, a biflavonoid with potential anticancer properties against viral oncoprotein E6 in Human papilloma virus-16 (HPV-16) positive cervical cancer cells\n4028: Amentoflavone regulates the miR-124-3p/CAPN2 axis to promote mitochondrial autophagy in HCC cells\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug74_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Dihydromyricetin\" (also known as \"dihydromyricetin\"), here are the article titles and their IDs:\n4018: Dihydromyricetin ameliorates experimental ulcerative colitis by inhibiting neutrophil extracellular traps formation via the HIF-1\u03b1/VEGFA signaling pathway\n4027: Dihydromyricetin Inhibits Ferroptosis to Attenuate Cisplatin-Induced Muscle Atrophy\n4037: Dihydromyricetin regulates RIPK3-CaMKII to prevent necroptosis in high glucose-stimulated cardiomyocytes\n4039: Dihydromyricetin treats pulmonary hypertension by modulating CKLF1/CCR5 axis-induced pulmonary vascular cell pyroptosis\n4042: Dihydromyricetin-loaded oxidized polysaccharide/L-arginine chitosan adhesive hydrogel promotes bone regeneration by regulating PI3K/AKT signaling pathway and MAPK signaling pathway\n4081: Dihydromyricetin ameliorates diabetic renal fibrosis via regulating SphK1 to suppress the activation of NF-\u03baB pathway\n4100: Dihydromyricetin suppresses endothelial NLRP3 inflammasome activation and attenuates atherogenesis by promoting mitophagy\n4144: Dihydromyricetin: an emerging compound with comprehensive effects on multiple systems\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug76_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Quercetin\" (also known as \"quercetin\"), here are the article titles and their IDs:\n4141: Quercetin's Potential in MASLD: Investigating the Role of Autophagy and Key Molecular Pathways in Liver Steatosis and Inflammation\n4191: Quercetin protective potential against nanoparticle-induced adverse effects\n4202: Metabolic effects of quercetin on inflammatory and autoimmune responses in rheumatoid arthritis are mediated through the inhibition of JAK1/STAT3/HIF-1\u03b1 signaling\n4215: A Systematic Review: Quercetin-Secondary Metabolite of the Flavonol Class, with Multiple Health Benefits and Low Bioavailability\n4218: From nature to clinic: Quercetin's role in breast cancer immunomodulation\n4222: Mechanistic study of quercetin in the treatment of hepatocellular carcinoma with diabetes via MEK/ERK pathway\n4246: Quercetin-functionalized nanomaterials: Innovative therapeutic avenues for Alzheimer's disease management\n4258: The bioavailability, absorption, metabolism, and regulation of glucolipid metabolism disorders by quercetin and its important glycosides: A review\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug77_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Oleoylethanolamide\" (also known as \"oleoylethanolamide\"), here are the article titles and their IDs:\n4180: Oleoylethanolamide attenuates acute-to-chronic kidney injury: in vivo and in vitro evidence of PPAR-\u03b1 involvement\n4189: Oleoylethanolamide and Palmitoylethanolamide Enhance IFN\u03b2-Induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells\n4221: Examining the oleoylethanolamide supplement effects on glycemic status, oxidative stress, inflammation, and anti-mullerian hormone in polycystic ovary syndrome\n4241: Effects of oleoylethanolamide supplementation on the expression of lipid metabolism-related genes and serum NRG4 levels in patients with non-alcoholic fatty liver disease: A randomized controlled trial\n4245: Oleoylethanolamide mitigates cardiometabolic disruption secondary to obesity induced by high-fat diet in mice\n4247: Oleoylethanolamide protects mesenchymal stem/stromal cells (MSCs) from oxidative stress and reduces adipogenic related genes expression in adipose-derived MSCs undergoing adipocyte differentiation\n4265: STING1-accelerated vascular smooth muscle cell senescence-associated vascular calcification in diabetes is ameliorated by oleoylethanolamide via improved mitochondrial DNA oxidative damage\n4281: Cannabinoid receptor 2 as a regulator of inflammation induced oleoylethanolamide in eosinophilic asthma\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug81_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"GHRP-2\" (also known as \"ghrp-2\"), here are the article titles and their IDs:\n4335: On the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse\n4338: Laparoscopic Sleeve Gastrectomy Resolves Low GHRP-2-Stimulated Growth Hormone Levels in Obese Patients\n4350: The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone\n4360: GHRP-2, GHRH and SRIF interrelationships during chronic administration of GHRP-2 to humans\n4382: Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans\n4393: Synergy of L-arginine and GHRP-2 stimulation of growth hormone in men and women: modulation by exercise\n4411: Changes in appetite and body weight in response to long-term oral administration of the ghrelin agonist GHRP-2 in growth hormone deficient children\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug83_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Ipamorelin\" (also known as \"ipamorelin\"), here are the article titles and their IDs:\n4342: Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus\n4345: Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus\n4349: Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers\n4351: The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats\n4354: The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus\n4357: Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients\n4363: The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism\n4369: Mechanism of ipamorelin-evoked insulin release from the pancreas of normal and diabetic rats\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug85_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"PT-141\" (also known as \"pt-141\"), here are the article titles and their IDs:\n4413: PT-141 Palatin\n4414: PT-141: a melanocortin agonist for the treatment of sexual dysfunction\n4415: Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra\n4416: Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response\n4417: Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction\n4418: An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug87_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Semaglutide\" (also known as \"semaglutide\"), here are the article titles and their IDs:\n4427: Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial\n4429: Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial\n4436: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide\n4455: Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial\n4489: Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials\n4512: Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial\n4515: Clinical Pharmacokinetics of Semaglutide: A Systematic Review\n4525: Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30-week, double-blind, phase 3a, randomized trial\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug88_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"TB-500\" (also known as \"tb-500\"), here are the article titles and their IDs:\n4457: Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro\n4460: Doping control analysis of TB-500, a synthetic version of an active region of thymosin \u03b2\u2084, in equine urine and plasma by liquid chromatography-mass spectrometry\n4463: Adsorption effects of the doping relevant peptides Insulin Lispro, Synachten, TB-500 and GHRP 5\n4465: Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug89_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Tirzepatide\" (also known as \"tirzepatide\"), here are the article titles and their IDs:\n4506: Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis\n4509: Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial\n4511: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity\n4546: Tirzepatide for Obesity Treatment and Diabetes Prevention\n4552: Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial\n4554: Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity\n4569: Tirzepatide for Weight Reduction in Chinese Adults With Obesity: The SURMOUNT-CN Randomized Clinical Trial\n4647: Tirzepatide for overweight and obesity management\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug91_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"SS-31\" (also known as \"ss-31\"), here are the article titles and their IDs:\n4610: SS-31 modification alleviates ferroptosis induced by superparamagnetic iron oxide nanoparticles in hypoxia/reoxygenation cardiomyocytes\n4614: SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome\n4618: SS-31 mitigates oxidative stress and restores mitochondrial function in cigarette smoke-damaged oral epithelial cells via PINK1-mediated mitophagy\n4620: Mitochondria-targeting peptide SS-31 attenuates ferroptosis via inhibition of the p38 MAPK signaling pathway in the hippocampus of epileptic rats\n4637: Genome-Wide CRISPR Screen Identifies Phospholipid Scramblase 3 as the Biological Target of Mitoprotective Drug SS-31\n4674: SS-31@Fer-1 Alleviates ferroptosis in hypoxia/reoxygenation cardiomyocytes via mitochondrial targeting\n4720: Discovery of novel SS-31 (d-Arg-dimethylTyr-Lys-Phe-NH2) derivatives as potent agents to ameliorate inflammation and increase mitochondrial ATP synthesis\n4728: Correction: Genome-Wide CRISPR Screen Identifies Phospholipid Scramblase 3 as the Biological Target of Mitoprotective Drug SS-31\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug95_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"DSIP\" (also known as \"dsip\"), here are the article titles and their IDs:\n4754: Delta sleep-inducing peptide (DSIP): a still unresolved riddle\n4756: DSIP in insomnia\n4786: Pichia pastorissecreted peptides crossing the blood-brain barrier and DSIP fusion peptide efficacy in PCPA-induced insomnia mouse models\n4805: A clinical trial with DSIP\n4806: [Olygopeptide KND as a putative endogenous prototype of delta sleep inducing peptide (DSIP). Comparative study of biological properties]\n4812: Effects of DSIP in man. Multifunctional psychophysiological properties besides induction of natural sleep\n4829: Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug97_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Melanotani\" (also known as \"melanotani\"), here are the article titles and their IDs:\n4761: Discovery and development of novel melanogenic drugs. Melanotan-I and -II\n4764: Skin pigmentation and pharmacokinetics of melanotan-I in humans\n4769: Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407\n4772: Pharmacologic response of a controlled-release PLGA formulation for the alpha-melanocyte stimulating hormone analog, Melanotan-I\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug98_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"GHK\" (also known as \"ghk\"), here are the article titles and their IDs:\n4817: GHK peptide prevents sleep-deprived learning impairment in aging mice\n4824: Intranasal GHK peptide enhances resilience to cognitive decline in aging mice\n4827: In situ photo-crosslinkable hyaluronic acid-based hydrogel embedded with GHK peptide nanofibers for bioactive wound healing\n4846: Behavioral and neuropathological features of Alzheimer's disease are attenuated in 5xFAD mice treated with intranasal GHK peptide\n4853: New Biotinylated GHK and Related Copper(II) Complex: Antioxidant and Antiglycant Properties In Vitro against Neurodegenerative Disorders\n4868: Tripeptides Ghk and GhkCu-modified silver nanoparticles for enhanced antibacterial and wound healing activities\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug100_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Mazdutide\" (also known as \"mazdutide\"), here are the article titles and their IDs:\n4825: A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity\n4828: Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial\n4831: Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial\n4836: Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials\n4837: Mazdutide Versus Dulaglutide for Weight Loss and Diabetes Management: Meta-Analysis of Randomized Clinical Trials\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug101_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Thymalin\" (also known as \"thymalin\"), here are the article titles and their IDs:\n4888: Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells\n4890: The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19\n4891: Effect of Thymalin on the Tumor and Thymus under Conditions of Activation Therapy In Vivo\n4902: [Effect of a levopromazine-thymalin combination on the development of toxic edema and swelling in the brain]\n4916: [Effectiveness of thymalin and prodigiozan in the complex treatment of patients with dysentery]\n4920: [Thymalin in the combined treatment of parkinsonism patients]\n4957: [Experimental and clinical study of a new immunoregulator preparation thymalin]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug103_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"LL-37\" (also known as \"ll-37\"), here are the article titles and their IDs:\n4944: LL-37, the master antimicrobial peptide, its multifaceted role from combating infections to cancer immunity\n5008: LL-37 promotes neutrophil extracellular trap formation in chronic rhinosinusitis with nasal polyps\n5073: Human Host Defense Peptide LL-37 Suppresses TNF\u03b1-Mediated Matrix Metalloproteinases MMP9 and MMP13 in Human Bronchial Epithelial Cells\n5122: Cathelicidin LL-37 in periodontitis: current research advances and future prospects - A review\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug106_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"P21\" (also known as \"p21\"), here are the article titles and their IDs:\n5063: CDKN1A/p21 in Breast Cancer: Part of the Problem, or Part of the Solution?\n5068: A p21-ATD mouse model for monitoring and eliminating senescent cells and its application in liver regeneration post injury\n5083: p21 facilitates chronic lung inflammation via epithelial and endothelial cells\n5092: The Emerging Role of p21 in Diabetes and Related Metabolic Disorders\n5110: Azurin Regulates P21 and Enhances the Sensitivity of Osteosarcoma Cells to Cisplatin\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug110_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Vitamin B12\" (also known as \"vitaminb12\"), here are the article titles and their IDs:\n5191: Maternal Vitamin B12 Status During Pregnancy and Its Association With Outcomes of Pregnancy and Health of the Offspring: A Systematic Review and Implications for Policy in India\n5199: Association of plasma folic acid, vitamin-B12 and homocysteine with recurrent pregnancy loss. \"A case control study\"\n5202: Vitamin B12 as a cholinergic system modulator and blood brain barrier integrity restorer in Alzheimer's disease\n5205: The role of Helicobacter pylori in vitamin-B12deficiency due to metformin use\n5207: Long-term effects of folic acid and vitamin-B12 supplementation on fracture risk and cardiovascular disease: Extended follow-up of the B-PROOF trial\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug113_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Avanafil\" (also known as \"avanafil\"), here are the article titles and their IDs:\n5238: Avanafil: A comprehensive drug profile\n5321: Avanafil Mitigates Testicular Ischemia/Reperfusion Injury via NLRP3 Pathway Modulation in Rats\n5340: Evaluation of the Effect on Sexual Performance of a Nutraceutical Combination Containing Alpha Lipoic Acid,Vitis viniferaL. andGinkgo biloba, Compared to Placebo, Avanafil or a Combination of Nutraceutical Plus Avanafil in Males With Type 2 Diabetes Mellitus With Erectile Dysfunction\n5347: Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study\n5349: A real-world pilot study assessing treatment satisfaction with avanafil in patients with erectile dysfunction\n5365: [Avanafil for the treatment of erectile dysfunction in practice. Non-interventional study AVANTI]\n5380: Synthesis and mutagenic risk of avanafil's potential genotoxic impurities\n5398: Inflammation in cerebral ischemia reperfusion improved by avanafil via nod-like receptor protein-3 inflammasome: an experimental study in rats\n5411: A phase 3, placebo controlled study of the safety and efficacy of avanafil for the treatment of erectile dysfunction after nerve sparing radical prostatectomy\n5446: An open-label, long-term evaluation of the safety, efficacy and tolerability of avanafil in male patients with mild to severe erectile dysfunction\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug114_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Cabergoline\" (also known as \"cabergoline\"), here are the article titles and their IDs:\n5264: Calcium versus cabergoline for prevention of ovarian hyperstimulation syndrome: A systematic review and meta-analysis\n5302: Cabergoline targets multiple pathways to inhibit PRL secretion and increases stromal fibrosis\n5356: Comparative efficacy of metformin combined with cabergoline versus metformin alone in patients with PCOS and hyperprolactinemia: A systematic review and meta-analysis of randomized controlled trials\n5358: Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing's disease\n5367: Comparing pyridoxine with dopaminergic agonists (cabergoline and bromocriptine): Unveiling the strategy for lactation inhibition - A systematic review of clinical trials\n5408: Cabergoline in the Management of Residual Nonfunctioning Pituitary Adenoma: A Single-Center, Open-Label, 2-Year Randomized Clinical Trial\n5431: Effect of Cabergoline on weight and glucose metabolism in patients with acromegaly\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug112_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Vitamin C\" (also known as \"vitaminc\"), here are the article titles and their IDs:\n5311: High-dose vitamin C on sepsis: Protocol of a prospective, multi-centered, double-blinded, randomized, and placebo-controlled superiority study\n5314: Vitamin C supplementation ameliorates liver function profile and antiviral treatment response in Hepatitis C patients\n5325: Vitamin C mitigates hematological and biochemical alterations caused by di(2-ethylhexyl) phthalate toxicity in female albino mice,Mus musculus\n5331: Vitamin C and E supplementation and high intensity interval training induced changes in lipid profile and haematological variables of young males\n5350: Co-Treatment with Cranberry and Vitamin-C Mitigates Reproductive Toxicities Induced by Phenobarbital in Male Rats\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug115_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Exemestane\" (also known as \"exemestane\"), here are the article titles and their IDs:\n5492: The effect of exemestane administration on the lipid profile in women: Meta-analysis of randomized controlled trials\n5517: Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive /human epidermal growth factor receptor 2 -advanced breast cancer (FRIEND study)\n5533: Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial\n5559: p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane\n5575: XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease\n5602: Tucidinostat Plus Exemestane as a Neoadjuvant in Early-Stage, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer\n5611: Phase II study of apatinib plus exemestane in estrogen receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug117_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Hexarelin\" (also known as \"hexarelin\"), here are the article titles and their IDs:\n5509: Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway\n5512: Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation\n5513: Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury\n5546: Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers\n5550: Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein\n5595: The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin\n5596: Using Synchrotron Radiation Imaging Techniques to Elucidate the Actions of Hexarelin in the Heart of Small Animal Models\n5604: Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery\n5662: Cardiac effects of hexarelin in hypopituitary adults\n5673: Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug118_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"LGD-4033\" (also known as \"lgd-4033\"), here are the article titles and their IDs:\n5562: Variation of Sequential Ligandrol (LGD-4033) Metabolite Levels in Routine Anti-Doping Urine Samples Detected with or without Other Xenobiotics\n5569: Investigation of in vitro generated metabolites of LGD-4033, a selective androgen receptor modulator, in homogenized camel liver for anti-doping applications\n5572: LGD-4033 and a Case of Drug-Induced Liver Injury: Exploring the Clinical Implications of Off-Label Selective Androgen Receptor Modulator Use in Healthy Adults\n5579: Investigations into the concentration and metabolite profiles of stanozolol and LGD-4033 in blood plasma and seminal fluid using liquid chromatography high-resolution mass spectrometry\n5585: Detection of LGD-4033 Metabolites in Camel Urine, Plasma, and Hair Following Oral Administration for Doping Control\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug124_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"S4\" (also known as \"s4\"), here are the article titles and their IDs:\n5675: A second S4 movement opens hyperpolarization-activated HCN channels\n5676: Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity\n5677: Carbonic anhydrase IX inhibitor S4 triggers release of DAMPs related to immunogenic cell death in glioma cells via endoplasmic reticulum stress pathway\n5693: A selective androgen receptor modulator, S4, displays robust anti-cancer activity on hepatocellular cancer cells by negatively regulating PI3K/AKT/mTOR signalling pathway\n5859: Unveiling the Potential of S4 on Non-small Cell Lung Cancer Cells: Impact on Proliferation, Apoptosis, Senescence, and Metabolome Profile\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug127_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Tamoxifen Citrate\" (also known as \"tamoxifencitrate\"), here are the article titles and their IDs:\n5699: Hyaluronic Acid and Graphene Oxide-incorporated Hyaluronic Acid Hydrogels for Electrically Stimulated Release of Anticancer Tamoxifen Citrate\n5703: Long-term tamoxifen citrate use and potential ocular toxicity\n5706: A combination of semi-purified L-methioninase with tamoxifen citrate to ameliorate breast cancer in athymic nude mice\n5716: Tamoxifen citrate therapy in male infertility\n5719: Box-Behnken Design-Aided Validation and Optimization of a Stability-Indicating Reverse Phase-HPLC Method for the Estimation of Tamoxifen Citrate in Lipidic Nano-Vesicles\n5733: A clomiphene citrate and tamoxifen citrate combination therapy: a novel therapy for ovulation induction\n5736: Enhancing Sperm Motility Parameters in Patients with Asthenospermia: A Combined Approach of Acupuncture at Fusiguan Point and Tamoxifen Citrate Tablets\n5780: Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in men with idiopathic oligozoospermia\n5785: Folic acid grafted mixed polymeric micelles as a targeted delivery strategy for tamoxifen citrate in treatment of breast cancer\n5789: The combination of testosterone undecanoate with tamoxifen citrate enhances the effects of each agent given independently on seminal parameters in men with idiopathic oligozoospermia\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug129_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Toremifene Citrate\" (also known as \"toremifenecitrate\"), here are the article titles and their IDs:\n5821: Silica xerogel carrier material for controlled release of toremifene citrate\n5823: In vitro evaluation of biodegradable epsilon-caprolactone-co-D, L-lactide/silica xerogel composites containing toremifene citrate\n5825: [Plasma concentrations of toremifene citrate and N-desmethyltoremifene in postmenopausal patients with breast cancer--comparison of 120 mg of toremifene citrate administered once a day and divided into 3 separate doses (t.i.d.)]\n5826: Effect of the molecular weight of poly(epsilon-caprolactone-co-DL-lactide) on toremifene citrate release from copolymer/silica xerogel composites\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug130_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Albuterol\" (also known as \"albuterol\"), here are the article titles and their IDs:\n5836: Airsupra: An inhaled albuterol/budesonide combination for asthma\n5840: Large-volume, preservative-free albuterol concentrate\n5843: Levalbuterolvs.albuterol for hospitalized patients with COPD in China: cost-utility and budget impact analysis\n5864: Change in Oxygen Consumption Following Inhalation of Albuterol in Comparison with Levalbuterol in Healthy Adult Volunteers\n5871: Levalbuterol is as effective as racemic albuterol in lowering serum potassium\n5877: Comparison of racemic albuterol and levalbuterol for treatment of acute asthma\n5884: Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthma\n5905: Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol\n5906: Changes in heart rate associated with nebulized racemic albuterol and levalbuterol in intensive care patients\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug131_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Argireline\" (also known as \"argireline\"), here are the article titles and their IDs:\n5862: Investigating the effects of Argireline in a skin serum containing hyaluronic acids on skin surface wrinkles using the Visia\u00aeComplexion Analysis camera system for objective skin analysis\n5870: The study of cellular cytotoxicity of argireline - an anti-aging peptide\n5879: The anti wrinkle efficacy of synthetic hexapeptide (Argireline) in Chinese Subjects\n5882: The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study\n5885: A synthetic hexapeptide (Argireline) with antiwrinkle activity\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug132_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Dapoxetine HCl\" (also known as \"dapoxetinehcl\"), here are the article titles and their IDs:\n5891: Mitigation of Rheumatic Arthritis in a Rat Model via Transdermal Delivery of Dapoxetine HCl Amalgamated as a Nanoplatform: In vitro and in vivo Assessment\n5893: Novel Enhanced Therapeutic Efficacy of Dapoxetine HCl by Nano-Vesicle Transdermal Gel for Treatment of Carrageenan-Induced Rat Paw Edema\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug135_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Gonadorelin\" (also known as \"gonadorelin\"), here are the article titles and their IDs:\n5954: Reproductive performance of goats treated with free gonadorelin or nanoconjugated gonadorelin at estrus\n5957: Gonadorelin increases semen production and does not affect its quality in Leporinus obtusidens\n5963: Effect of using 200 \u03bcg of gonadorelin at the first gonadotropin-releasing hormone of the breeding-Ovsynch on ovulatory response and pregnancies per artificial insemination in first-service lactating Holstein cows\n5968: Effect of different gonadorelin (GnRH) products used for the first or resynchronized timed artificial insemination on pregnancy rates in postpartum dairy cows\n5987: Spray congealed solid lipid microparticles as a sustained release delivery system for Gonadorelin [6-D-Phe]: Production, optimization and in vitro release behavior\n5990: Impact of phase of the estrous cycle and season on LH surge profile and fertility in dairy cows treated with different GnRH analogs (gonadorelin vs. buserelin)\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug140_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Mirabegron\" (also known as \"mirabegron\"), here are the article titles and their IDs:\n6014: Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial\n6038: Activation of \u03b23-adrenergic receptor by mirabegron prevents aortic dissection/aneurysm by promoting lymphangiogenesis in perivascular adipose tissue\n6167: Safety and efficacy of an \u03b11-blocker plus mirabegron compared with an \u03b11-blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta-analysis\n6229: MIRABEGRON INDUCED RELAXATION OF ISOLATED BOVINE CORONARY SEGMENTS: ROLE OF NO AND K+ CHANNEL\n6231: Efficacy of mirabegron, a \u03b23-adrenoreceptor agonist, in Japanese women with overactive bladder and either urgency urinary incontinence or mixed urinary incontinence: Post-hoc analysis of pooled data from two randomized, placebo-controlled, double-blind studies\n6237: Mirabegron, dependent on \u03b23-adrenergic receptor, alleviates mercuric chloride-induced kidney injury by reversing the impact on the inflammatory network, M1/M2 macrophages, and claudin-2\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug139_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Triptorelin\" (also known as \"triptorelin\"), here are the article titles and their IDs:\n6044: GnRH analogue triptorelin acetate induces ovulation in jennies during oestrus\n6054: Cost-Effectiveness Analysis of Triptorelin, Goserelin, and Leuprolide in the Treatment of Patients With Metastatic Prostate Cancer: A Societal Perspective\n6069: Effects of water-soluble additive on the release profile and pharmacodynamics of triptorelin loaded in PLGA microspheres\n6098: Adult height in girls with idiopathic central precocious puberty treated with triptorelin\n6104: A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty\n6124: A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin Acetate\n6139: An open and randomized study comparing the efficacy of standard danazol and modified triptorelin regimens for postoperative disease management of moderate to severe endometriosis\n6166: Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug144_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"AICAR\" (also known as \"aicar\"), here are the article titles and their IDs:\n6099: AICAR confers prophylactic cardioprotection in doxorubicin-induced heart failure in rats\n6126: AICAR Ameliorates Non-Alcoholic Fatty Liver Disease via Modulation of the HGF/NF-\u03baB/SNARK Signaling Pathway and Restores Mitochondrial and Endoplasmic Reticular Impairments in High-Fat Diet-Fed Rats\n6145: AMPK activation by AICAR reduces diet induced fatty liver in C57BL/6 mice\n6158: An intrinsic purine metabolite AICAR blocks lung tumour growth by targeting oncoprotein mucin 1\n6219: AICAR administration affects glucose metabolism by upregulating the novel glucose transporter, GLUT8, in equine skeletal muscle\n6267: Administration of AICAR, an AMPK Activator, Prevents and Reverses Diabetic Polyneuropathy (DPN) by Regulating Mitophagy\n6282: Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients\n6309: Urine levels of 5-aminoimidazole-4-carboxamide riboside (AICAR) in patients with type 2 diabetes\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug146_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"B7-33\" (also known as \"b7-33\"), here are the article titles and their IDs:\n6257: B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin)\n6259: B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice\n6261: The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy\n6262: Coatings Releasing the Relaxin Peptide Analogue B7-33 Reduce Fibrotic Encapsulation\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug149_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Cardiogen\" (also known as \"cardiogen\"), here are the article titles and their IDs:\n6302: Tumor-modifying effect of cardiogen peptide on M-1 sarcoma in senescent rats\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug151_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Cerebrolysin\" (also known as \"cerebrolysin\"), here are the article titles and their IDs:\n6347: Add-on treatment with Cerebrolysin improves clinical symptoms in patients with ALS: results from a prospective, single-center, placebo-controlled, randomized, double-blind, phase II study\n6369: Cerebrolysin provides effective protection on high glucose-induced neuropathy in cultured rat dorsal root ganglion neurons\n6384: Efficacy, safety, and cost-effectiveness analysis of Cerebrolysin in acute ischemic stroke: A rapid health technology assessment\n6423: Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial\n6431: Cerebrolysin potentiates the antidepressant effect of lithium in a rat model of depression\n6437: Cerebrolysin in Patients Diagnosed with Subarachnoid Hemorrhage-The Results of an Observational Cohort Study\n6452: Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke\n6492: Treatment with Cerebrolysin Prolongs Lifespan in a Mouse Model of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug154_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Cortagen\" (also known as \"cortagen\"), here are the article titles and their IDs:\n6351: [Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia]\n6353: Effect of tetrapeptide cortagen on regeneration of sciatic nerve\n6359: Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug157_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"GHRH\" (also known as \"ghrh\"), here are the article titles and their IDs:\n6372: GHRH and the prostate\n6374: GHRH in diabetes and metabolism\n6378: Effects of GHRH and its analogues on the Vascular System\n6381: GHRH and reproductive systems: Mechanisms, functions, and clinical implications\n6412: Growth hormone-releasing hormone receptor (GHRH-R) and its signaling\n6438: Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients\n6572: Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug158_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Humanin\" (also known as \"humanin\"), here are the article titles and their IDs:\n6506: Humanin activates integrin \u03b1V-TGF\u03b2 axis and leads to glioblastoma progression\n6606: Humanin P3S, haplogroup N1b and the risk of Alzheimer's disease\n6632: Humanin attenuates metabolic, toxic, and traumatic neuropathic pain in mice by protecting against oxidative stress and increasing inflammatory cytokine\n6673: Humanin-G Ameliorates Hemorrhage-Induced Acute Lung Injury in Mice Through AMPK\u03b11-Dependent and -Independent Mechanisms\n6689: Unbalanced circulating Humanin levels and cardiovascular risk in chronic hemodialysis patients: a pilot, prospective study\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug159_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Lipopeptide\" (also known as \"lipopeptide\"), here are the article titles and their IDs:\n6548: Anti-Toxoplasma gondiiEffects of Lipopeptide Derivatives of Lycosin-I\n6595: Lipopeptide C17Fengycin B Exhibits a Novel Antifungal Mechanism by Triggering Metacaspase-Dependent Apoptosis inFusarium oxysporum\n6621: A Synthetic Multivalent Lipopeptide Derived from Pam3CSK4 with Irreversible Influenza Inhibition and Immuno-Stimulating Effects\n6666: Dilarmycins A-C, Calcium-Dependent Lipopeptide Antibiotics with a Non-canonical Ca2+-Binding Motif\n6687: A promising antifungal lipopeptide from Bacillus subtilis: its characterization and insight into the mode of action\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug160_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Liraglutide\" (also known as \"liraglutide\"), here are the article titles and their IDs:\n6630: Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study\n6661: Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial\n6730: Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality\n6745: Liraglutide Improves Myocardial Perfusion and Energetics and Exercise Tolerance in Patients With Type 2 Diabetes\n6756: Liraglutide alleviates ferroptosis in renal ischemia reperfusion injury via inhibiting macrophage extracellular trap formation\n6783: Effects of liraglutide on body composition in people living with obesity or overweight: A systematic review\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug161_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Livagen\" (also known as \"livagen\"), here are the article titles and their IDs:\n6692: Effects of Livagen peptide on chromatin activation in lymphocytes from old people\n6696: [Functional morphology of an organotypic liver culture exposed to the peptide livagen]\n6704: [Effect of new peptide bioregulators livagen and epitalon on enkephalin-degrading enzymes in human serum]\n6712: [Effect of peptide Livagen on activity of digestive enzymes in gastrointestinal tract and non-digestive organs in rats of different ages]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug162_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Longevity\" (also known as \"longevity\"), here are the article titles and their IDs:\n6790: Advancing Longevity: Exploring Antiaging Pharmaceuticals in Contemporary Clinical Trials Amid Aging Dynamics\n6792: Genetic Support for Longevity-Enhancing Drug Targets: Issues, Preliminary Data, and Future Directions\n6830: Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders\n6863: Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity\n6865: Structure and function analysis of adiponectin receptors toward development of novel antidiabetic agents promoting healthy longevity\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug173_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Pancragen\" (also known as \"pancragen\"), here are the article titles and their IDs:\n6900: Effects of pancragen on the differentiation of pancreatic cells during their ageing\n6901: Effect of pancragen on blood glucose level, capillary permeability and adhesion in rats with experimental diabetes mellitus\n6902: Prospects of using pancragen for correction of metabolic disorders in elderly people\n6903: [Correction of impaired glucose tolerance using tetrapeptide (Pancragen) in old female rhesus monkeys]\n6904: [Impact of tetrapeptide pancragen on endocrine function of the pancreas in old monkeys]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug175_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Pinealon\" (also known as \"pinealon\"), here are the article titles and their IDs:\n6905: Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes\n6906: Pinealon protects the rat offspring from prenatal hyperhomocysteinemia\n6907: [Pinealon and Cortexin influence on behavior and neurochemical processes in 18-month aged rats within hypoxia and hypothermia]\n6908: [Regulation of content of cytokines in blood serum and of caspase-3 activity in brains of old rats in model of sharp hypoxic hypoxia with Cortexin and Pinealon]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug186_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Protirelin\" (also known as \"protirelin\"), here are the article titles and their IDs:\n6931: Dose-response studies with protirelin\n6933: Protirelin (thyrotropin-releasing hormone) in thyroid gland: possible involvement in regulation of thyroid status\n6934: TRH (protirelin) in depressed alcoholic men. Behavioral changes and endocrine responses\n6940: Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients\n6943: Thyrotropin-releasing hormone (protirelin) inhibits potassium-stimulated glutamate and aspartate release from hippocampal slices in vitro\n6944: Behavioral effects of protirelin in schizophrenia\n6947: [Neuropsychologic and clinical effects of protirelin tartrate in patients with stroke sequelae]\n6951: [Pharmacokinetics and pharmacodynamics of protirelin (TRH) in man]\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug191_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Vilon\" (also known as \"vilon\"), here are the article titles and their IDs:\n6956: Immunomodulating effects of Vilon and its analogue in the culture of human and animal thymus cells\n6957: Effect of peptide Vilon on the content of transforming growth factor-beta and permeability of microvessels during experimental chronic renal failure\n6959: Inhibitory effect of peptide vilon on the development of induced rat urinary bladder tumors in rats\n6963: [Effect of vilon on the immunity status and coagulation hemostasis in patients of different age with diabetes mellitus]\n6969: [Effect of dipeptide vilon on emotional stress resistance in rats]\n6976: Effect of the dipeptide vilon on activity of digestive enzyme in rats of various ages\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug192_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"VIP\" (also known as \"vip\"), here are the article titles and their IDs:\n6973: Study effect of MAPA-VIP on control of allergic asthma pathophysiology\n6989: Ablation of microRNAs in VIP+interneurons impairs olfactory discrimination and decreases neural activity in the olfactory bulb\n7001: Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study\n7006: Heme and Cu2+-induced vasoactive intestinal peptide (VIP) tyrosine nitration: A possible molecular mechanism for the attenuated anti-inflammatory effect of VIP in inflammatory diseases\n7018: Vasoactive Intestinal Peptide (VIP) and its Receptors in Adipose Tissue: Implications for Cold Stress Adaptation\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug193_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Aminotadalafil\" (also known as \"aminotadalafil\"), here are the article titles and their IDs:\n7069: Simultaneous identification of hydroxythiohomosildenafil, aminotadalafil, thiosildenafil, dimethylsildenafil, and thiodimethylsildenafil in dietary supplements using high-performance liquid chromatography-mass spectrometry\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug195_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Ibutamoren\" (also known as \"ibutamoren\"), here are the article titles and their IDs:\n7072: Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren\n7074: Characterization of growth hormone secretagogue small molecule ibutamoren (MK-0677) and its possible metabolites in thoroughbred horses for doping control\n7076: Characterization of equine liver microsome-generated metabolites of growth hormone secretagogue small molecule ibutamoren\n7079: Antiviral activity of sertindole, raloxifene and ibutamoren against transcription and replication-competent Ebola virus-like particles\n7082: Investigating the P53-dependent anti-cancer effect of ibutamoren in human cancer cell lines\n7085: Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children\n7088: MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug194_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Enclomiphene\" (also known as \"enclomiphene\"), here are the article titles and their IDs:\n7078: Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism\n7080: Safety and efficacy of enclomiphene and clomiphene for hypogonadal men\n7083: Efficacy of Clomiphene Citrate Versus Enclomiphene Citrate for Male Infertility Treatment: A Retrospective Study\n7090: Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone\n7091: Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement\n7093: Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel\n7111: Serum levels of enclomiphene and zuclomiphene in men with hypogonadism on long-term clomiphene citrate treatment\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug196_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"MT-2\" (also known as \"mt-2\"), here are the article titles and their IDs:\n7081: Diversity of cell phenotypes among MT-2 cell lines affects the growth of U937 cells and cytokine production\n7089: MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance\n7094: FoxO1 regulates apoptosis induced by asbestos in the MT-2 human T-cell line\n7106: Evaluation of the effects of Quercetin and Kaempherol on the surface of MT-2 cells visualized by atomic force microscopy\n7116: Inhibitory effects of anti-oxidants on apoptosis of a human polyclonal T-cell line, MT-2, induced by an asbestos, chrysotile-A\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug198_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Minoxidil\" (also known as \"minoxidil\"), here are the article titles and their IDs:\n7141: A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men\n7154: Injectable Minoxidil for Hair Loss Disorders: A Systematic Review\n7157: A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss\n7163: Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement\n7167: Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials\n7183: Efficacy and safety of compound glycyrrhizin combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials\n7239: Comparative efficacy of minoxidil alone versus minoxidil combined with low-level laser therapy in the treatment of androgenic alopecia: a systematic review and meta-analysis\n7255: Minoxidil in severe hypertension\n7324: Topical minoxidil for male pattern baldness\n7335: Minoxidil and captopril in severe hypertension\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug200_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"B-12\" (also known as \"b-12\"), here are the article titles and their IDs:\n7151: Proton Pump Inhibitors, H2-Receptor Antagonists, Metformin, and Vitamin B-12 Deficiency: Clinical Implications\n7177: Efficacy of B12Fortified Nutrient Bar and Yogurt in Improving Plasma B12 Concentrations-Results From 2 Double-Blind Randomized Placebo Controlled Trials\n7197: Vitamin B-12 supplementation improves arterial function in vegetarians with subnormal vitamin B-12 status\n7203: Vitamin B-12-deficiency affects immunoglobulin production and cytokine levels in mice\n7229: Methylmalonic Acid and Homocysteine as Indicators of Vitamin B-12 Deficiency in Cancer\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug203_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"DMAA\" (also known as \"dmaa\"), here are the article titles and their IDs:\n7173: Have prohibition policies made the wrong decision? A critical review of studies investigating the effects of DMAA\n7198: Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA)\n7204: Nine prohibited stimulants found in sports and weight loss supplements: deterenol, phenpromethamine (Vonedrine), oxilofrine, octodrine, beta-methylphenylethylamine (BMPEA), 1,3-dimethylamylamine (1,3-DMAA), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylbutylamine (1,3-DMBA) and higenamine\n7246: Running an unknown risk: a marathon death associated with the use of 1,3-dimethylamylamine (DMAA)\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug205_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Trestolone Acetate\" (also known as \"trestoloneacetate\"), here are the article titles and their IDs:\n7336: Potential interaction between exogenous anabolic steroids and sugammadex: failed reversal of rocuronium in a patient taking testosterone and trestolone acetate\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug207_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"Diisopropylaminedichloroacetate\" (also known as \"diisopropylaminedichloroacetate\"), here are the article titles and their IDs:\n7338: Diisopropylamine dichloroacetate enhances radiosensitization in esophageal squamous cell carcinoma by increasing mitochondria-derived reactive oxygen species levels\n7340: The antitumor effect of diisopropylamine dichloroacetate on non-small cell lung cancer and its influence on the tumor immune microenvironment\n7341: Fenbendazole and Diisopropylamine Dichloroacetate Exert Synergistic Anti-cancer Effects by Inducing Apoptosis and Arresting the Cell Cycle in A549 Lung Cancer Cells\n7342: Diisopropylamine dichloroacetate, a novel pyruvate dehydrogenase kinase 4 inhibitor, as a potential therapeutic agent for metabolic disorders and multiorgan failure in severe influenza\n7344: Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
{"custom_id": "drug208_order", "method": "POST", "url": "/v1/chat/completions", "body": {"model": "gpt-4o-mini", "messages": [{"role": "user", "content": "For the research chemical \"DNSp-11\" (also known as \"dnsp-11\"), here are the article titles and their IDs:\n7343: Methodology and effects of repeated intranasal delivery of DNSP-11 in awake Rhesus macaques\n7347: Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1/2 phosphorylation in vitro\n7349: Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease\n\nRank these articles in order of importance for a customer seeking to understand the drug's effects.\nAssign a ranking order where 1 is the most important.\nReturn a JSON object mapping article IDs to their rank numbers (integers), with no extra text.\nOutput:"}], "max_tokens": 300, "temperature": 0.0}}
